Analysis of Domain Specific Functions of the Ceramide Synthase Schlank in <em>Drosophila melanogaster</em> by Wulf, Anna-Lena
Analysis of Domain Specific Functions of
the Ceramide Synthase Schlank in
Drosophila melanogaster
Dissertation
zur Erlangung des Doktorgrades (Dr. rer. nat.)
der
Mathematisch-Naturwissenschaftlichen Fakultät
der
Rheinischen Friedrich-Wilhelms-Universität Bonn
vorgelegt von
Anna-Lena Wulf
aus Detmold
Bonn, 2015

Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät
der Rheinischen Friedrich-Wilhelms-Universität Bonn.
Erstgutachter: PD Dr. Reinhard Bauer
Zweitgutachter: Prof. Dr. Klaus Willecke
Tag der Promotion: 04. Dezember 2015
Erscheinungsjahr: 2016

Eidesstattliche Erklärung
Hiermit versichere ich, dass diese Dissertation von mir selbst und ohne unerlaubte
Hilfe angefertigt wurde. Es wurden keine anderen als die angegebenen Hilfsmittel be-
nutzt. Ferner erkläre ich, dass die vorliegende Arbeit an keiner anderen Universität
als Dissertation eingereicht wurde.
Bonn, Juni 2015
Anna-Lena Wulf

Summary
Ceramide synthases (CerS) are integral membrane proteins at the center of sphin-
golipid (SL) biosynthesis. Their enzymatic activity is dependent on the conserved lag1
motif, but from cnidarians onwards many CerS proteins also contain a homeodomain
with yet unknown function. Homeodomains are commonly known as DNA-binding
domains in transcription factors regulating developmental processes. Previous studies
of our group show that the only CerS ortholog in Drosophila melanogaster -Schlank-
is not only involved in the synthesis of SLs but also in the regulation of body fat.
This regulation seems to be independent on the CerS activity. Lately, Schlank was
shown to localize in the nucleus in an Importin dependent manner. In this thesis,
the functional properties of the Schlank protein were studied in more detail. A ge-
nomic engineering strategy where specific mutations were introduced into the schlank
sequence in it’s endogenous locus allowed the direct comparison of Schlank variants.
This approach could prove that up regulation of lipase 3 in schlank deficient larvae is
due to the absence of the Schlank protein, and not due to absent ceramide synthesis.
Mutations within the homeodomain targeting a putative nuclear localization signal
(NLS) caused phenotypes in locomotion, behavior and body fat level that are also
known from schlank P-element mutant alleles, further implying a functional relevance
of the homeodomain. Mutations in this NLS reduced the relative amount of nuclear
Schlank protein showing it’s functionality in vivo, whereas mutations in the other pre-
dicted NLS did not reduce nuclear Schlank. To address a potential nuclear function of
the homeodomain Schlank transmembrane topology was investigated experimentally.
Those experiments strongly suggest a cytosolic and nucleoplasmic orientation of the
homeodomain. Previously, a cleavage of the Schlank protein has been proposed. As
Schlank fragment bands were detected to a different extend under different conditions
a regulated reasonable cleavage of the Schlank protein could be hypothesized. Unex-
pectedly, the site of this cleavage was localized to an amino acid stretch within the
homeodomain. Altogether, with this work we gained more insight into the various
roles of the Schlank protein apart from it’s catalytic activity.
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1 Introduction
Biological lipid species are highly versatile. Cell membranes contain more lipid species
than needed to form a simple lipid bilayer (Bretscher, 1973) and lipid composition
seems to be important for different signaling events (Pepperl et al., 2013). Addi-
tionally, bioactive lipids have been found that themselves have signaling properties
(Hannun and Obeid, 2008). For the analysis of the influence of different metabo-
lites on physiology, more and more (animal) models of enzyme deficiencies have been
generated and analyzed in the last years (Padmanabha and Baker, 2014). However,
manipulating biosynthesis pathways can have unclear effects that could e.g. arise from
adapted regulation of other metabolizing enzymes or lack of the manipulated enzyme
itself.
1.1 Sphingolipids
Sphingolipids are a class of lipids that arose parallel to the appearance of eukaryotic life
and are conserved from yeast to mammals. They were first isolated and characterized
from brain extracts in the 1870s (Thudichum, 1874). Sphingolipids are highly diverse
and play an important role in the determination of membrane properties (Guan et al.,
2009; Silva et al., 2012). They are also involved in signaling events, like their influence
on cell recognition, on the behavior of growth factor receptors and extracellular matrix
proteins (Hakomori, 1990), on lipid microdomain function (van Zanten et al., 2010;
Harder and Simons, 1997; Grassmé et al., 2007) or on the generation of micro-channels
within mitochondrial membranes (Siskind et al., 2002; Colombini, 2010). Some are
considered bioactive lipids involved in survival, stress response and apoptosis (Hannun
and Obeid, 2008).
The distribution of sphingolipids within subcellular compartments varies (Hannich
et al., 2011) and little is known about the overall regulation of sphingolipid metabolism
even though many intermediates show high impact on cell survival. The uptake of
sphingolipids with food does not appear to be essential but may be a functional com-
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ponent of food (Vesper et al., 1999). In rodents they are taken up by intestinal cells
in the form of ceramide or sphingoid bases and degraded to fatty acids or reincorpo-
rated into complex sphingolipids that remain associated primarily with the intestine
(Nilsson, 1968; Schmelz et al., 1994).
Sphingolipid synthesis is organized along the secretory pathway. Sphingoid bases,
the backbones of sphingolipids, are synthesized at the endoplasmic reticulum (ER).
They can be acylated by Ceramide Synthases to form (dihydro)ceramide, which can
be subsequently modified. Most of those (complex) sphingolipid species are synthe-
sized in the Golgi apparatus. The carbon chain length and saturation of the acyl
chain residues, and the different modifications of the sphingoid bases like phosphory-
lation or addition of choline or sugar residues/branches lead to the high variability of
sphingolipids (fig. 1.1).
The de novo biosynthesis of sphingolipids starts with the condensation of L-serine
and palmitoyl-CoA (in Drosophila lauryl-CoA) by the Serine Palmitoyl Transferase
(SPT). Resulting 3-keto-sphinganine is reduced to sphinganine. Sphinganine is acy-
lated by a Ceramide Synthase and desaturated by a Ceramide Desaturase to form
Ceramide (fig. 1.1). Ceramides can be directly transported to the Golgi in a non-
vesicular mechanism by the Ceramide Transporter protein (CERT, Hanada et al.,
2003) but also through vesicular transport. The Golgi is the site of synthesis of sphin-
gomyelin and glucosylceramide, which is the precursor for complex glycosphingolipids.
Delivery of sphingomyelin and complex glycosphingolipids to the plasma membrane
appears to occur by vesicular transport. The endosomal pathway is involved in the
degradation and salvage of sphingolipids (Hannun and Obeid, 2008).
In the last years more and more diseases have been linked to aberrations in sphin-
golipid levels and their metabolizing enzymes. E.g.:
– Sphingolipidoses are lipid storage diseases resulting mainly from defects in the
degradation of sphingolipids like Niemann-Pick disease, Fabry disease, Gaucher
disease and Tay-Sachs disease (Pentchev and Barranger, 1978; Sandhoff, 2012).
– Sphingolipids have been associated with neuronal apoptosis and therefore neu-
rodegeneration (Arboleda et al., 2009) like Alzheimer’s disease (Farooqui et al.,
2010; Mielke and Lyketsos, 2010; van Echten-Deckert and Walter, 2012) and
Parkinson’s disease (Abbott et al., 2014).
– Studies show, that sphingolipids are associated with the development of metabolic
syndrome. E.g. inhibiting de novo ceramide synthesis reduces insulin resistance
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Figure 1.1: Sphingolipid species. Sphingoid bases -here Sphingosine- are N-acylated by
Ceramide Synthases to form ceramide, a simple sphingolipid. Different groups can be added
at C1 by different enzymes to form more complex sphingolipids. Some abundant are listed
in the table. PE: phosphoethanolamine, R: residue. Ceramide backbone modified from
Neumann and van Meer, 2008.
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(Holland and Summers, 2008; Holland et al., 2007b; Ussher et al., 2010), and
serum levels of sphingomyelin with distinct saturated acyl chains correlate with
the parameters of obesity, insulin resistance, liver function and lipid metabolism
in patients (Hanamatsu et al., 2014).
– The ceramide/sphingosine-1-phosphate rheostat is important in cancer devel-
opment and progression (Ogretmen and Hannun, 2004). Whereas ceramide is
a pro-apoptotic signaling molecule, sphingosine-1-phosphate has counteracting
function promoting proliferation, differentiation and migration in various cell
types (Oskouian and Saba, 2010).
Therefore, sphingolipd metabolism is more and more considered as a therapeutic
target and a diagnostic marker. A good understanding of the enzymes involved is
fundamental for the development of such new tools.
1.2 Sphingolipids and sphingolipid metabolizing
enzymes in Drosophila
In Drosophila melanogaster, most of the enzymes of the sphingolipid metabolism are
described and are encoded by less paralogs than in mammals (Acharya and Acharya,
2005). The lipidome of Drosophila melanogaster during development has been ana-
lyzed via mass spectrometry (Carvalho et al., 2012; Guan et al., 2013). For several
enzymes of the sphingolipid biosynthesis pathways mutants have been described. For
example, ceramide kinase (cerk) mutants accumulate ceramide and show reduced en-
ergy levels. Metabolic adaption occurs via the Akt/FOXO pathway, enhancement
of glycolysis and lipolysis in the gut. Ceramide Kinase phosphorylates ceramide to
form ceramide-1-phosphate (Nirala et al., 2013). Alkaline ceramidase mutants show
increased lifespan and anti-oxidative stress capacity. Ceramidases catalyze the hydrol-
ysis of ceramides to generate sphingosine and fatty acids (Yang et al., 2010). Metabo-
lites, like glucosylceramide, sphingosine-1-phosphate and ceramide have been linked
to fat storage in Drosophila (Kohyama-Koganeya et al., 2011; Walls et al., 2013).
Even though there are Sphingomyelinases encoded in the genome, sphingomyelin is
nearly absent. Drosophila Sphingomyelinases could be responsible for the generation
of the more abundant phosphoethanolamine ceramide (PE-ceramide; Kraut, 2011).
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1.3 Ceramide Synthases
Ceramide Synthases (CerS) catalyze the reaction of sphinganine (or sphingosine) and
a fatty acylCoA to form (dihydro-) ceramide (+CoA). Therefore, they are right at the
center of sphingolipid metabolism (Mullen et al., 2012).
These enzymes belong to a family of transmembrane proteins containing a con-
served TLC (Tram, Lag and CLN8) domain (Winter and Ponting, 2002; fig. 1.2). The
contained lag1 motif is important for the catalytic activity of CerS (Spassieva et al.,
2006). An additional ("new") motif essential for catalytic activity has been reported
by Mesika et al. (2007). Since cnidarians onwards many CerS contain a homeodomain
(Voelzmann and Bauer, 2010; Holland et al., 2007a) usually associated with sequence
specific DNA interaction of transcription factors during development (Gehring and
Hiromi, 1986; Gehring et al., 1994a). Studies on the transmembrane topology re-
vealed a cytoplasmic C-terminus for yeast CerS (Lag1p and Lac1p) and mouse CerS6
(Kageyama-Yahara and Riezman, 2006; Mizutani et al., 2005).
Figure 1.2: Domain structure of Ceramide Synthases. There are CerS proteins without a
homeodomain e.g. CerS1 and Lac1p and CerS proteins with a homeodomain N-terminally
to the TLC domain e.g. CerS2 and Schlank. HOM (blue): homeodomain, TLC (green):
TLC domain, dark green: lag motif.
Mammals encode six CerS (CerS1-CerS6), each with a different tissue distribution
and preferred chain length of fatty acylCoA (Levy and Futerman, 2010; Stiban et al.,
2010; Kremser et al., 2013). For example, CerS1 - the only mammalian CerS without
a homeodomain- is mainly expressed in muscle and brain and has a preference for
C18-acylCoA, CerS2 shows the over-all highest abundance in most tissues and has
a preference for very long chain acylCoAs (C20-C26). It is hypothesized that sph-
ingolipids with different chain length fulfill different functions (Grösch et al., 2012;
Menuz et al., 2009). This is also seen in the different phenotypes of the deficient mice
for each ceramide synthase that have been generated (CerS1: Zhao et al., 2011; Ginkel
et al., 2012, CerS2: Imgrund et al., 2009; Pewzner-Jung et al., 2010a,b; Park et al.,
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2013; Zigdon et al., 2013, CerS3: Jennemann et al., 2012; Rabionet et al., 2015, CerS4:
Ebel et al., 2014; Peters et al., 2015, CerS6: Ebel et al., 2013; Turpin et al., 2014).
1.4 Drosophila melanogaster Ceramide Synthase:
Schlank
The Drosophila melanogaster genome encodes one ceramide synthase gene (schlank,
CG3576, Drosophila longevitiy assurance gene-1 homologue(DLag1)) that is ubiqui-
tously expressed (Acharya and Acharya, 2005; Bauer et al., 2009; Voelzmann and
Bauer, 2011). Schlank has been shown to be a bona fide Ceramide Synthase that is
involved not only in sphingolipid metabolism but also in the regulation of body fat.
schlank mutant larvae show (amongst other things) a strong reduction in triacylglyc-
erol (TAG) level that goes along with an up regulation of lipases (lipase 3, brummer)
and adipokinetic hormone, and a down regulation of SREBP and its target genes (e.g.
fatty acid synthase, acetylCoA synthase) that reverse upon schlank over expression.
This reversion occurs independent of the capability of the over expressed Schlank pro-
tein to form ceramide (Bauer et al., 2009; Voelzmann, 2013; fig. 1.3). As therefore the
regulation of body fat should depend on the (N-terminal part of the) Schlank protein
itself and as the Schlank protein is a homeodomain containing Ceramide Synthase we
hypothesize a gene regulatory function of the CerS homeodomain. Additional find-
ings supporting this hypothesis, are the nuclear localization of endogenous Schlank
protein in fat body cells of stage 3 larvae, putative nuclear localization signals (NLSs)
and 3D-structure and DNA binding properties of the Schlank homeodomain (fig. 1.4;
Voelzmann, 2013; Noyes et al., 2008). The more common opinion however seems
to consider the CerS homeodomain as an evolutionary artifact (Venkataraman and
Futerman, 2002).
Schlank deficiency also results in many different phenotypes including developmental
delay, lethality, modified wingless signaling and defects during eye development and
glial ensheathment of axons (Bauer et al., 2009; Pepperl et al., 2013; Voelzmann, 2013;
Ghosh et al., 2013). Two schlank mutant lines have been analyzed; one stronger allele
(schlankP (X)349) and one weaker allele (schlankP (X)61) that differ in the level of schlank
expression and therefore in the severity of the phenotype. Larvae of the stronger allele
die at the first larval stage whereas there are escapers of the weaker mutant allele that
even develop to adulthood.
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Figure 1.3: Schlank is a player of lipid homeostasis; insulin-and feeding-independent. Mod-
ification of Schlank level results in an adaption of triacylglycerol (TAG) level via the reg-
ulation of genes involved in lipogenesis (srebp and target genes) and lipolysis (brummer,
lipase 3 ). This regulation, especially lipase 3, seems to be independent of the ability of the
Schlank enzyme to synthesize ceramide (catalytically inactive, SchlankH215D) or the pres-
ence of the C-terminus (Schlank AA1-138). The picture shows an L3 larva of schlankP (X)61:
it is thinner and contains less fatbody than control (w1118) larva even though both took up
the red stained yeast. n.d.: not determined.
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1.5 The CerS homeodomain and nuclear sphingolipid
metabolism
Several sphingolipid species have been isolated from nuclear extracts (e.g. sphin-
gomyelin, sphingosine-1-phosphate, sphingosine, ganglioside GM1; Albi et al., 2003;
Wu et al., 1995), as well as sphingolipid metabolizing enzyme activity (e.g. Sphin-
gomyelin Synthase, neutral Sphingomyelinase, Ceramidase, Sphingosine-Kinase; Albi
and Magni, 1999; Tsugane et al., 1999; Hait et al., 2009). The nuclear sphingolipids
have been associated with regulatory and structural functions like chromatin dynam-
ics, histone acetylation and apoptosis, suggesting a nuclear sphingolipid metabolism
(Lucki and Sewer, 2012).
TheDrosophila Ceramide Synthase Schlank shows nuclear localization as well (Voelz-
mann, 2013; fig. 1.4C). The nuclear import mechanism could be proven to be Ketel
dependent, which is a Drosophila homologue of Importin-β. This classical nuclear
import mechanism is based on the binding of transport receptors (e.g. Importin-β) to
nuclear localization signals (NLS) within the sequence of transported cytoplasmic or
membrane proteins and their transfer through the nuclear pore complex (NPC; Sorokin
et al., 2007). NLSs are highly divers, making predictions complicated (Kosugi et al.,
2009). Two putative NLSs have been found in the Schlank homeodomain sequence
(fig. 1.4B) which were involved in the nuclear localization of Schlank homeodomain
constructs in cell culture experiments (Voelzmann, 2013).
Homeodomains show a classical 3D-structure with three helices in a helix–loop–helix
–turn–helix motif (Scott et al., 1989, fig. 1.4A). Consensus residues in helix 3 and in
the N-terminal arm contact DNA. All 84 independent homeodomains from Drosophila
melanogaster have been analyzed concerning their DNA-binding specificity. Also for
the Schlank homeodomain a consesus sequence was determined (Noyes et al., 2008).
1.6 Regulation of body fat
Many metabolic pathways are conserved in human and fly. Manipulation of those
pathways in Drosophila gives rise to e.g. diabetic or obese phenotypes that are also
observed in patients (Bharucha, 2009). A metabolically active organ in the fly is the
fatbody ( a functional analogue of adipose tissue in humans). It stores e.g. triacyg-
lycerols (TAGs), cholesterol ester and glycogen and, like mammalian adipocytes, it is
full of lipid droplets. Together with the oenocytes located in the cuticle it also fulfills
9
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Figure 1.4: Schlank nuclear localization and homeodomain. A: 3D structure of CerS home-
odomains and classical homeodomains are much alike. X-ray based 3D structure of the clas-
sical homeodomains Ultrabithorax from Drosophila melanogaster (Dm Ubx) and pancreatic
and duodenal homeobox 1 from Mesocricetus auratus (Ma Pdx1), NMR based 3D structure
of the Mus musculus CerS6 homeodomain (Mm CerS6) and the SWISS MODEL prediction
of the Schlank homeodomain (Dm Slak). B: Sequence analysis showed two nuclear localiza-
tion signals within the Schlank homeodomain. C: Schlank localizes to the nucleus. L3 larval
fatbody was stained in immunofluorescence analysis: Schlank: green, Lamin (inner nuclear
membrane, INM): red, DAPI (DNA): blue. Modified from Voelzmann, 2013.
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the storage function and metabolic regulation of mammalian liver (Gutierrez et al.,
2007). Instead of pancreatic cells, specific areas of the brain are responsible for the re-
lease of Drosophila Insulin-Like-Peptides (DILPs) and the Glucagon-like Adipokinetic
hormone (Akh) which systemically controls body fat mobilization. Conserved key
regulator genes of lipogenesis are e.g. the Akh receptor (AkhR) target midway which
encodes the Drosophila Diacylglycerol O-Acyltransferase 1 (DmDGAT1) (Buszczak
et al., 2002; Baumbach et al., 2014), srebp and it’s target genes (e.g. fatty acid syn-
thase (fas), acetylCoA synthase (acs)) which are involved in the synthesis of fatty
acids (Dobrosotskaya et al., 2002). In the cholesterol auxotrophs Drosophila, phos-
phatidylethanolamine regulates the activity of SREBP. SREBP is a membrane bound
transcription factor that is cleaved by the proteases S1P and S2P upon cellular de-
mand for fatty acids, freeing the transcription factor domain from the membrane to
enter the nucleus and to direct the increased transcription of target genes. Regulator
genes of lipolysis are e.g. lipases like brummer, the Drosophila homologue of human
adipocyte triacylglyceride lipase (Grönke et al., 2005) and lipase 3, which is highly
up regulated upon starvation (Zinke et al., 1999). Lipase 3 is expressed in the larval
fatbody and shows high similarity to lysosomal lipases from human and rat (Pistillo
et al., 1998).
1.7 Proteases
Proteases (peptidases, proteinases, proteolytic enzymes) are a group of enzymes whose
catalytic function it is to hydrolyze peptide bonds. Depending on the active site
residue or ion that carries out the catalysis they can be divided into five groups:
serine, threonine, cysteine, aspartic and metallo proteases. The activity of proteases
is highly regulated. Substrate recognition and specificity depends on a variety of
factors such as structural properties of the active site, subcellular compartment and
surface accessibility.
In the past, proteases were considered primarily as protein degrading enzymes in-
volved in the digestion and the removal of miss-folded proteins. Now this view has
changed as they are known to be important players in signaling events (Ehrmann and
Clausen, 2004). Yet, only a minor subset of physiological substrates and protease has
been identified (Turk et al., 2012). They play a role in important signaling cascades
such as the regulation of apoptosis, unfolded protein response (UPR) and develop-
ment (Hay and Guo, 2006; Patil and Walter, 2001; Ye and Fortini, 2000). Proteolysis
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can influence signaling e.g. by the removal of regulatory proteins/domains (e.g. Cas-
pases, Spaetzle (Toll ligand), Hedgehog) and the influence on a protein’s subcellular
localization like the release of a formerly membrane tethered domain (e.g. SREBP,
Notch, Amyloid Precursor Protein (APP), ATF6). Proteolytic cleavage of a protein
can also occur within their transmembrane domains (regulated intramembrane prote-
olysis; RIP) which has also been shown for the cleavage of SREBP by S2P (Rawson,
2003).
1.8 Aims
Aim of this thesis was the further analysis of the the domain specific function of
the Drosophila melanogaster Ceramide Synthase Schlank, especially focusing on the
homeodomain and the nuclear localization. Additionally, the putative endoproteolytic
processing that has been observed was investigated in more detail.
The transmembrane topology of the Schlank protein could solve, whether the home-
odomain faces the cytosol -and therefore, the nucleoplasm- enabling DNA-interaction.
A schlank knock out line should be established based on a method published by Huang
et al. (2009). With this method, specific distinct mutations can be introduced into
the schlank sequence making it possible to study the mutation’s impact on fly phys-
iology without dealing with over expression and wildtype background artifacts. First
mutations analyzed affect the nuclear localization signals and the catalytic activity
of the Schlank protein. Additionally, the observed feeding dependent endoproteolytic
processing of the Schlank protein should be analyzed in more detail, including the
occurrence in different states (e.g. development, mutants) and the cleavage site.
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2 Material
2.1 General materials
Chemicals
Chemicals were purchased from Roche, Promega, Merck, Roth, Invitrogen, Sigma-
Aldrich, Bio-Rad, Stratagene, Qiagen, Machery-Nagel and Fermentas.
Consumables
Common laboratory equipment Faust, Schütt
test/reaction tubes Roth, Eppendorf
Plastic wares Greiner
microscope slides VWR
PVDF membrane Merck Millipore
Screw cap glasses Pyrex, Bibby Sterlin Ltd
X-ray films Fuji Medical X-Ray Film Super RX; BW Plus
[14C] Acetic acid GE (Amersham)
Equipment
Autoclave H+P Varioklav Dampfsterilisator EP-2
Agarose gel chambers Peqlab
Bacteria incubator Innova 44 New Brunswick scientific
Balances Sartorius BL 150 S
Sartorius B211 D
Binocular S2X 12 and SZ 40, Olympus
Stemi 2000, Zeiss
Blotting eqipment BioRad
Centrifuges J-26 XP, Avanti
X 15R, Allegra
AV-720, Beckmann Coulter
5415 R and 5424 R, Eppendorf
Confocal microscope Zeiss LSM710
Developer machine Curix 60 AGFA
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2.1 General materials
Electro pipette Accu Jet
Gel documentation Alpha Digi Doc, Biozym
Homogenizer Precellys Peqlab
Imaging plates (Screens) GE
PCR machine C1000 Thermal Cycler BioRad
MJ Research PTC-200 Peltier Thermal Cycler
Photometer Nano Drop 2000 PeqLab
pH-Meter FiveEasy FE20, Mettler Toledo
Pipettes Eppendorf Research
Plate reader Fluostar Omega (BMG Labtech)
RealTime PCR machine iCycler BioRad
Speed-Vac Speed-Vac SPD 111, Savant
Thermomixer Thermomixer comfort, Eppendorf
Ultrasonic apparatus Bandelin SONOPLUS HD2070
Voltage source Power Pac BioRad
Vortexer Vortex Genie2
Water bath Julabo SW22
Software
Adobe Photoshop
Alpha Digi Doc Biozym
CellF Olympus
Clone Manager Sci-Ed
Fiji is just ImageJ
iQ5-Optical System Software Bio-Rad
Microsoft Office 2010
Primer3
Scribus
Zen Light 09 Zeiss
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Standards and kits
Nucleic Acid & Protein Purification, Macherey & Nagel
NucleoBond, PC 100
BCA Protein Assay Pierce
ECL Western Blotting Substrate Pierce
SuperSignal West Pico,
SuperSignal West Femto
Restore Western Blot Stripping Kit Pierce
iQTM SYBR Green Supermix Biorad
QuantiTect, Reverse Transcription Kit Qiagen
Ready-to-use System for fast Purification of Nucleic Macherey & Nagel
Acids, NucleoSpin, Extract II
Nucleic Acid & Protein Purification, NucleoSpin, RNAII Macherey & Nagel
NucleoSpin RNA/Protein Macherey & Nagel
PCR Nucleotide Mix Roche
Q5 Site-Directed Mutagenesis Kit NEB
NucleoSpin RNA XS Macherey & Nagel
DAPI-Fluoromount G Biozol
NucleoSpin Plasmid QuickPure Macherey & Nagel
2-Log DNA ladder NEB
Precision Plus Protein All Blue Standards Biorad
Figure 2.1: Nucleic acid and protein standards.
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2.2 Buffers and solutions
Unless otherwise noted, all buffers and solutions were made with double distilled water
(A. bidest) and were kept at RT.
General solutions
PBS− (pH 7,2) 133 mM NaCl
2,7 mM KCl
8,1 mM Na2HPO4
1,5 mM KH2PO4
10x TBS (pH 7,5) 100 mM Tris
500 mM NaCl
Work with nucleic acids
Squishing buffer (SB) 10 mM Tris-HCl
(pH 8,2) 25 mM NaCl
1 mM EDTA
freshly add
200 µg/µl Proteinase K
Proteinase K - 20 mg/ml Proteinase K
stock solution
DNA-loading dye (6x) 0,25 % (v/v) Bromphenolblue
0,25 % (v/v) Xylencyanol
30 % (v/v) Glycerol
SYBR Safe 10 mg/ml SYBR Safe (Invitrogen)
protect from light
TAE-Puffer (pH 8,0) 2 M Tris
(10 x) 100 mM EDTA
adjust pH with acetic acid
Sodium acetate s 3 M Sodium acetate
(pH 4,8) autoclave 1 h
RNase 20 mg RNase A
ad 10 ml. A. bidest.,
15 min at 100◦C
store aliquots at -20◦C
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Alkali 1 50 mM D(+)-Glukose
25 mM Tris
10 mM EDTA
freshly add 1 µl/ml RNase
Alkali 2 0,2 M NaOH
1 % SDS
Alkali 3 3 M Potassium acetate
5 M Acetic acid
Work with protein
RIPA 10 mM Na2HPO4
(pH 7,2) 10 mM NaH2PO4
0,1 % SDS
40 mM Sodium fluoride
2 mM EDTA
1 % Triton-X-100
0,1 % Deoxycholate
1x complete protease inhibitor
5x Laemmli 100 mM Tris-HCl
(pH 6,8) 3 % (w/v) SDS
10 % (v/v) Glycerol
0,01% (w/v) Bromphenol blue
5 % (v/v) 2-Mercapto-ethanol
SDS-Running buffer 0,25 M Tris
10x 1,92 M Glycine
1 % (w/v) SDS
Transfer-buffer (10x) 0,25 M Tris
1,5 M Glycine
Transfer-buffer (1x) 100 ml Transfer-buffer (10x)
200 ml Methanol
ad 1 l A. bidest
1x TBS-T 0,2 % (v/v) Tween 20
in 1x TBS
Blocking solution 7 % (w/v) Milk powder in TBS-T
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Stainings
PBT 0,2 % Triton X 100
in 1x PBS
Phospate buffer 36 ml Na2HPO4 0,2 M
(pH 7,2) 14 ml NaH2PO4 0,3 M
50 ml A. bidest
40 mM Natriumfluorid
Methylene blue 1 g Methylen blue
6 g Borax
1 g Boric acid
ad 100 ml A.bidest
Toluidine blue 1 g Methylen blue
6 g Borax
1 g Boric acid
ad 100 ml A.bidest
Toluidine blue stain 1:1 Methylene blue:Toluidine blue
2.3 Media
Ampicillin-Stocks. 5 % (w/v) Ampicillin
ad 50 ml A.bidest
store aliquots at -20◦C
final conc. in selection media
50 µg/ml
LB-Agar (pH 7,4) 1,5 % (w/v) Agar
1 % (w/v) NaCl
1 % (w/v) Trypton
0,5 %(w/v) Yeast-Extract
ad 1 l, autoclave
if necessary add antibiotics
LB-Medium (pH 7,4) 1 % (w/v) NaCl
1 % (w/v) Trypton
0,5 %(w/v) Yeast-Extract
ad 1 l, autoclave
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Injection buffer, pH
6.8
5 mM KCl
0,1 mM NaPO4
Nipagine-solution 147 ml Ethanol
63 ml A. bidest
21 g Nipagine
Apple juice agar 1 l Apple juice
100 g Sugar
85 g Agar
40 ml Nipagine (15 %)
3 l A.bidest
Fly food 80 g Agar
165 g Dry yeast
815 g Maise flour
1 l Zuckerrübensirup
10 % Nipagine
11 l Water
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2.4 Enzymes
Complete Protease-Inhibitors Roche
DNase I Roche
Go-Taq Polymerase Promega
T4-Ligase Roche
Phusion Hot Start II Polymerase Thermo-Scientific
PNGase F New England Biolabs
Proteinase K Roth
rAPid Alkaline Phosphatase Roche
Restriction endonukleases New England Biolabs
RNase A Sigma Aldrich
2.5 Antibodies
The following antibodies were used in the concentrations indicated. IF immunofluo-
rescence analysis, IB immunoblotting.
Primary Antibodies
Antibodies Host species Dilution Company/ Reference
αSchlank CT guinea pig IB: 1:500 pHD thesis Andre Voelzmann
sheep IF: 1:50
αSchlank HOM rabbit IB: 1:250 Bauer et al. (2009)
αLamin mouse IF: 1:20 DSHB
αSpectrin mouse IF: 1:20 DSHB
αActin rabbit IB: 1:500 Sigma
αHA rat IF: 1:100, IB: 1:400 Roche
αGFP rabbit IB: 1:200 Santa Cruz Biotech
mouse IB: 1:200 Santa Cruz Biotech
goat IB: 1:200 Santa Cruz Biotech
chicken IF: 1:100 Abcam
Secondary Antibodies
Antibodies Host species Dilution Company/ Reference
Alexa 488 anti-mouse goat IF: 1:200 Molecular Probes
Alexa 488 anti-chicken goat IF: 1:200 Molecular Probes
Alexa 647 anti-rat goat IF: 1:200 Molecular Probes
Cy3 anti-rat goat IF: 1:200 Molecular Probes
Cy3 anti-sheep goat IF: 1:200 Molecular Probes
HRP anti-rabbit goat IB: 1:10000 Santa Cruz Biotech
HRP anti-rat goat IB: 1:10000 Santa Cruz Biotech
HRP anti-guinea pig goat IB: 1:10000 Santa Cruz Biotech
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2.6 Vectors
Vector Reference/Source
pUAST Brand and Perrimon (1993)
pGX-attP Huang et al. (2009)
pGE-attB Huang et al. (2009)
pAc 5.1 Invitrogen
2.7 Oligonucleotides
Following primers were used for qRT-PCR, genotyping and cloning. Mutations in-
troduced via mutagenesis PCR are written boldly. Primer names starting with Q-
indicate the use of the Q5 mutagenesis kit (NEB). Restriction sites are noted in the
primer name or application column.
qRT-Primer
Gene Sequence for primer (5’→ 3’) Sequence rev primer (5’→ 3’)
rp49 gctaagctgtcgcacaaatg gttcgatccgtaaccgatgt
actin gtgcaccgcaagtgcttctaa tgctgcactccaaacttccac
schlank gccaactacaaggacctc atgccaagtgatttgcct
lipase3 tgagtacggcagctacttccct tcaacttgcggacatcgct
brummer acgcacagcagcgacatgtat cttttcgctttgctacgagcc
akh ggtcctggaacctttttcgag ttgcacgaagcggaagatc
srebp cgcagtttgtcgcctgatg cagactcctgtccaagagctgtt
fas ccccaggaggtgaactctatca gacttgaccgatccgatcaac
acs aaatcccatggaccgatgac tgtagagcatgaacaatggatcct
midway aagacaggcctctactattgt cccatcatgcccataaatgcc
pink gctttcccctaccctccac gcactacattgaccaccgatt
parkin agcctccaagcctctaaatg cacggactctttcttcatcg
usp30 ttcgctaaactaccggcctg gctctcggggaagtgtacat
atg1 aggattcagtctcccaatcttgtactg cagtacaagattgggagactgaatcct
atg8 cgtcattccaccaacatcgg gccatgccgtaaacattctc
atg18 gccattggaatgtgaaatgct ggcaactcaaatatcaaagcga
Primer for genotyping
PCR and genotype Sequence for primer (5’→ 3’) Sequence rev primer (5’→ 3’)
PCR 3’HR (schlankKO) ttcgggcccgacgcaaggag cgaaatggcggcaggtccaattg
PCR 5’HR (schlankKO) agccggcaacgaatttcccacaaaatatta ggttaccccagttggggcactac
PCR 1 (schlankKO) tccatcatacacactatatatgcctgc tggtacggctacccgcatcag
PCR 2 (schlankKO) gtaagtgtggagccatgtggcc ccggcagatcctttatccgatgg
PCR attR (schlankKI) gcgacgacaggtgtgtgtgcg cagatagataaactgagggccagataatg
PCR attL (schlankKI) gggcgacacggaaatgttgaatactc gaatgattttccatttattgaaatgaaactaggattc
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Primer for cloning
Primer Primer sequence Application
name (5’→ 3’)
SCHLANK KO
5’HRschlankfor cgagatccgcggcaattagcacctc cloning of shorter 5’HR
tcattcatct
5’HRschlankrev cgagatggtacctgctatctatctt SacII, KpnI
cgagaccgac
fw5HRelongation gcatgcaatgcggccgctaccgcgg elongation of 5’HR (final)
cccactccatcttcaagttcct
rev5HRelongation ggttctttggattttggacgacg
3’HRSlkBglIfor cgagatagatctcgaaaaaaagcgg cloning of longer 3’HR
gacggcatcat
3’HRSlkAvrIIrev cgagatcctaggccttgttctctac
atcggataaacattctgagtaaac
3’HRSlkBglIIfor s.a. cloning of 3’HR (final)
1,7kbrev3hrarm gcttacctagggctgaacgcaacca
aggtggg
SCHLANK KI
RescueSlkFLfor tcagtggctagcgttccatagccaa cloning
gattacaatag
RescueSlkFLrev tcagtgctcgagaaacacgtttgtt XhoI, NheI
ttttggtc
mutagenesis:
NLS1rpkkrpmm for agttctaggcctatgatggcggcaaatg NLS1
NLS1rpkkrpmm rev catttgccgccatcataggcctagaact
NLS2rlrralar for agcgctggtgggctctagccagggcccagg NLS2
NLS2rlrralar rev cctgggcggtggctagagcccaccagcgct
lagH215D for neu cagatgttcatcgatcacatggtcacc H215D
lagH215D rev neu ggtgaccatgtgatcgatgaacatctg
Q-E118A-for ccaccagcgcgcgatttcgcg E118A
Q-E118A-rev cgtctacgcagagctcaggataaacc PspOMI → SacI
CELL CULTURE
HA-TAGLAG1NTfor ggaattcaacatggactacccatac cloning of HA-schlank
gatgttccagattacgctatattga EcoRI
atgagttcagcaatgta
SchlankXhoI-rev gatctcgagctactcctctctccg
ttccgttg
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mutagenesis of
pAcHAschlank:
N21Q-for tggctgccgccgcaaacaacctgggcg N21Q
N21Q-rev cgcccaggttgtttgcggcggcagcca
K94N-for aagacctatgccaactcgacgcgattg K94N
K94N-rev caatcgcgtcgagttggcataggtctt
P130N-for gcccaggataaaaattcaacgctggtg P130N
P130N-rev caccagcgttgaatttttatcctgggc
63-NST-64-for gctacacgctggagcgtttcaactcaacg 63NST64
tggatatcgcccgtaggcaa
63-NST-64-rev ttgcctacgggcgatatccacgttgagtt
gaaacgctccagcgtgtagc
74-NST-75-for ggcaaatcacttggcatatacccatac 74NST75
gatgttccagattacgctaactcaacg XbaI
tctagacgtagttctaggcctaag
74-NST-75-rev cttaggcctagaactacgtctagacgttg
agttagcgtaatctggaacatcgtatggg
tatatgccaagtgatttgcc
84-NST-85-for ggcctaagaaagcggcaaataactcaacg 84NST85
gttcctattctggagaagac
84-NST-85-rev gtcttctccagaataggaaccgttgagtt
atttgccgctttcttaggcc
105-NST-106-for acaagaaaaagctggttccgaactcaacg 105NST85
ctgtccaagcagacggatat
105-NST-106-rev atatccgtctgcttggacagcgttgagtt
cggaaccagctttttcttgt
119-NST-120-for gcgagcgcgaaatcgagcgcaactcaacg 119NST120
tggtggcgtctacgcagggc
119-NST-120-rev gccctgcgtagacgccaccacgttgagtt
gcgctcgatttcgcgctcgc
178-NST-HA-179-for ccgcatcagtcgatcaactcaacgtaccca 178NSTHA179
tacgatgttccagattacgcttctaga XbaI
agcaatgatatctgg
178-NST-HA-179-rev ccagatatcattgcttctagaagcgtaat
ctggaacatcgtatgggtacgttgagttg
atcgactgatgcgg
Q-301-for tacccatacgatgttccagattacgct 301NSTNSTHA302
ccagcctactacatc EcoRI
Q-301-rev cgttgagttgaattccgttgagtt
gaacatgggcagaat
348-NST-EcoRI-for gatagtgagaactcaacggaattc 348NST349
gatctcacagacagt EcoRI
348-NST-EcoRI-rev tgtgagatcgaattccgttgagtt
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ctcactatcactgga
98-STOP-XhoI-for aaatcgacgcgattgtagctcgag 98STOP
aagctggttccgctg XhoI
98-STOP-rev cagcggaaccagcttctcgagcta
caatcgcgtcgattt
138-STOP-XhoI-for gtgaagttctgcgagtagctcgag 138STOP
cgttgcatctactat XhoI
138-STOP-rev atagtagatgcaacgctcgagcta
ctcgcagaacttcac
HA-TAGLAG1NTfor ggaattcaacatggactacccatac HAschlank 1-88
gatgttccagattacgctatattga
atgagttcagcaatgta
88stop-XhoI-rev gatctcgagttacagaataggaaca
tttgccgctttc
HA-TAGLAG1NTfor s.a. HAschlank 1-108
108stop-XhoI-rev gatctcgagttacttggacagcggaa
ccagctttttc
UAS LINES
cloning of:
HA-TAGLAG1NTfor s.a. HAschlank 1-98
1-98-stop-XhoI-rev gatctcgagttatcgcgtcgatttg
gcataggtctt
99-400-EcoRI-for gatgaattcatggacaagaaaaagc schlank 99-400HA
tggttccgctg
Schlank-HA-XhoI-rev gatctcgagctaagcgtaatctgga
acatcgtatgggtactcctctctcc
gttccgttg
DELETION
CONSTRUCTS
HA-TAGLAG1NTfor s.a. HAschlankMYC
MYC-LAG1-CT-rev ccgctcgagcggttacagatcctct
tcagagatgagtttctgctcctcct
ctctccgttccgttgtcgcaa
HA-TAGLAG1NTfor s.a. HAschlankGFP
GFP-rev tctgggccctcacttgtacagctcg
tccatgc
mutagenesis of
pUAST
HAschlankMYC:
del1-for atgagcgagcgcgaaatcgagaaac del119-128
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cgtcaacgctggtgaag
del1-rev cttcaccagcgttgacggtttctcg
atttcgcgctcgctcat
del2-for cgtctacgcagggcccaggataaca del129-138
cgtggcgttgcatctac
del2-rev gtagatgcaacgccacgtgttatcc
tgggccctgcgtagacg
del3-for acgctggtgaagttctgcgagttca del139-148
tctttggcgtgatcgtg
del3-rev cacgatcacgccaaagatgaactcg
cagaacttcaccagcgt
del4-for tgggacaagccctggttttggcatc del165-174
agtcgatcagcaatgat
del4-rev atcattgctgatcgactgatgccaa
aaccagggcttgtccca
dFur-for tcgagcgctggtggggtctacgcgg 122
ggcccaggataaaccg RLRR → GLRG
dFur-rev cggtttatcctgggccccgcgtaga
ccccaccagcgctcga
mutagenesis of
pUAST
HAslakGFP:
Q-del-minus3-for gacaagaaaaagcttgttccgctgtccaa del89-98
Q-del-minus3-rev cagaataggaacatttgccgctttcttagg HindIII
Q-NL-for aaaaagctggttccgctgtccaagcag del95-100
Q-NL-rev tttggcataggtcttctcgagaataggaac XhoI
Q-delH2-for acggatatgagcgagcgc del101-109
Q-delH2-rev cttgtccaatcgcgtcgatttggcataggtc XhoI
ttctcgag
Q-del-90-110-for gatatgagcgagcgcgaa del90-110
Q-del-90-110-rev ctcgagaataggaacatttgc XhoI
HeGFPdel-1F ggcatacgtagttctcagcctcagc 3xNLS
aagcggcaaatgttcctattctgga (mutagenesis on
gaagacctatgccaaatcgacgcga pUAST
ttggacgaggaagagctggttccgc HAschlank)
HeGFPdel-1R gacggtttatcctgggcttgctgta
gctgccaccagcgctcgatttcgcg
ctcgctcatatccgtctgcttggac
agcggaaccagctcttcctcgtcca
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2.8 Bacterial strains
Bacterial strain used for plasmid amplification.
E.coli-strain Genotype Source
DH5α F-endA1 deoR (ϕ80lacZ∆M15) recA1 gyrA
(Nalr) thi-1 hsdR17 Stratagene
(rK−, mK+) supE44 relA1 ∆(lacZYA-argF)U169
2.9 Fly lines
Name Source/Reference
white− (w−) Bloomington #6326
hsGal 4 Hoch lab stock collection
hs-flp;dicer2;act>CD2>Gal 4,UAS-GFP Hoch lab stock collection
CG Gal 4 Bloomington #7011
UAS-HAschlank Bauer et al. (2009)
UAS-schlankHA Bauer et al. (2009)
UAS-schlank HA1-98 this thesis
UAS-schlank 99-400HA this thesis
UAS-HAschlankMYC this thesis
UAS-HAschlankGFP this thesis
UAS-HAschlankMYC ∆119-128 this thesis
UAS-HAschlankMYC ∆129-138 this thesis
UAS-HAschlankMYC ∆139-148 this thesis
UAS-HAschlankMYC ∆165-174 this thesis
UAS-HAschlankMYC ∆122RLRR → GLRG this thesis
UAS-HAschlankGFP ∆89-98 this thesis
UAS-HAschlankGFP ∆95-100 this thesis
UAS-HAschlankGFP ∆101-109 this thesis
UAS-HAschlankGFP ∆90-110 this thesis
UAS-HAschlank 3xNLS this thesis
UAS-schlankRNAi Bauer et al. (2009)
schlankP (X)61 = schlankG0061 Bauer et al. (2009)
schlankP (X)349 = schlankG0349 Bauer et al. (2009)
schlankKO this thesis
schlankKI−WT this thesis
schlankKI−NLS1 this thesis
schlankKI−NLS2 this thesis
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schlankKI−H215D this thesis
schlankKI−E118A this thesis
dcerk mutant Nirala et al. (2013)
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3 Methods
3.1 Generation and treatment of transgenic flies
3.1.1 Fly handling
Fly keeping and propagation was carried out after standard procedures. Flies were
kept on 25◦C for experimental use unless otherwise mentioned and on 18◦C - RT for
stock keeping. For crosses, 1-30 virgins were crossed to approximately half to the
same amount of male flies. For the collection of progeny crosses or fly stocks were
transferred into cages where the flies lay their eggs on applejuice-agar plates with
some fresh yeast paste put in the middle. Collections were carried out for different
time points and afterward kept on 25◦C until progeny was in the desired stage for the
experiment. If necessary afterwards first instar larvae were sorted under the fluorescent
binocular for the absence of the GFP or YFP marker on the balancer chromosome
(e.g. FM7, dfdeYFP).
For nomenclature: different chromosomes are sepaprated by semicolon, different
alleles of the same chromosome by slash, different constructs on the same chromosome
by comma, wildtype chromosomes are +. If not mentioned otherwise fly lines were
available in the laboratory.
3.1.2 P-element transgenesis
P-elements are mobile genetic elements that can be used as tools to create transgenes
and mutations. Modified P-Elements are used as transformation-vectors in Drosophila
melanogaster where one vector encodes the transposase (helper plasmid) and a second
vector contains the inverted repeats flanking the sequence that should be inserted
into the genome (Spradling and Rubin, 1982; Rubin and Spradling, 1982). Injections
were carried out using standard procedures (Roberts et al., 1986) in the lab by Sabine
Büttner or by the BestGene Inc.
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Injections of pUAST vectors into white eyed flies (white−, w1118) enabled the identifi-
cation of transgenes by red eye color, as pUAST encodes the white gene. Identification
of the insertion chromosome was carried out by crossing to balancer fly lines. The fly
stocks were kept homozygously or heterozygously over a balancer chromosome.
3.1.3 Gal4-UAS System
The Gal4-UAS system is an ectopic expression system to over express transgenes
in a certain temporal and spatial manner in Drosophila melanogaster (Brand and
Perrimon, 1993). Driver lines or activator strains express the yeast transcription factor
Gal4 under the control of a certain enhancer. UAS lines or effector strains carry the
upstream activator sequence (UAS) in front of a geneX. After crossing those lines Gal4
binds to UAS and the geneX is expressed.
3.1.4 Ends Out Gene Targeting
For a generation of a schlank null mutant/schlankKO line with the possibility to re-
introduce schlank-DNA, Ends Out Gene Targeting was performed (Huang et al., 2008,
2009). The target sequence is replaced by a donor sequence via homologous recombi-
nation. The donor sequence contains a white gene for selection flanked by loxP sites
to allow the removal of the selection gene by crossing to a Cre-recombinase express-
ing fly line. Additionally, the donor sequence contains an attP site that allows the
re-introduction of DNA-fragments targeted to the schlankKO locus.
Generation of a schlank knock out line
5’ and 3’ homologous regions (HR) were cloned into the donor vector pGX-attP which
contains the donor sequence, a UAS-reaper sequence, 5’ and 3’ P-element sequences
and FRT and SceI sites to excise and linearize the donor construct ( see section
??). The vector was used to generate the donor fly line via P-element transgenesis.
Lines were selected for red eye color and insertion chromosome was found out (as
the schlank gene is localized on the X-chromosome, donor lines were chosen were the
P-element inserted on the 2nd or 3rd chromosome). Then, the donor lines were tested
for their ability to mobilize the donor construct (by crossing to yw/Y,hs-hid;hs-Flp,hs-
I-SceI/CyO,hs-hid;+/+ flies, heat shock of the progeny to activate Flp and SceI and
screen for mosaic eyes resulting from the loss of the white gene where the mobiliza-
tion occurred) and for the functionality of the apoptosis gene reaper (by crossing to
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yw/Y;Pin/CyO;Gal4221w−/Gal4221w− flies that express Gal4 under the control of a
strong neuronal promotor and screening for pupal lethaliy). UAS-reaper allows the
identification of false-positive lines as the sequence gets lost if homologous recombina-
tion was successful.
The generation of the schlankKO line was carried out with the following crosses:
Targeting cross:
yw
Y,hs−hid ;
hs−Flp,hs−I−SceI
CyO,hs−hid ;
+
+ x
w
w
; P{donor}rpr+
P{donor}rpr+ ;
+
+
Before homologous recombination the donor construct has to be mobilized and lin-
earized. FRT sites are recognized and recombined by the Flippase (Flp). The resulting
circular DNA-fragment is linearized by SceI. Both enzymes are expressed under the
control of a hs-promotor. Crosses (≈30) were kept on 25◦C, flipped every day and
progeny was heat shocked in the water bath (38◦C, 90 min) on day 2 and 3.
Screening cross:
yw
Y
; Pin
CyO
; Gal4221w−
Gal4221w− x
yw
schlankKO
; hs−Flp,hs−I−SceI∆donorrpr+ ;
+
+
From the targeting cross resulting mosaic eyed virgins were collected (male progeny
carries the cell death gene hid induced by heat shock) and crossed to males of the
"screening"-line. Noted here is the genotype after excision of the donor sequence and
the UAS-reaper and successful homologous recombination. The majority of potential
targeting events may be unspecific and not located on the X-chromosome.
Mapping cross:
FM6
Y
; ++ ;
+
+ x
yw
schlankKO
; Pin−or−CyO
hs−Flp,hs−I−SceI−or−∆donorrpr+ ;
Gal4221w−
+
Red eyed progeny from the screening cross that did not show any reaper phenotype
were crossed to a balancer line. Only red eyed females were crossed as a schlankKO
would result in homozygous or hemizygous lethality like the stronger schlank mutant
alleles. The progeny was then screened for male lethality (no males with red eyes
should be obtained) and females with red and kidney shaped eyes (resulting from
the bar mutation in the balancer) were crossed to males of the balancer line again to
obtain a stable stock.
To screen for schlank related lethality females of the putative schlankKO lines were
crossed to males carrying the schlank mutant allele (schlankP (X)349 on the X-chromosome
and a duplication of the Y-chromosome:
schlankP (X)349
Y dp
; ++ ;
+
+ x
schlankKO
FM6 ;
+
+ ;
+
+
This should result in progeny with red eyed males (schlankKO/Ydp) but no red eyed
females without "bar" eyes (schlankP (X)349schlankKO lethal).
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3.1 Generation and treatment of transgenic flies
The schlankKO lines were kept as stable stocks over the balancers FM7dfdeYFP or
FM7krGal4UASGFP to allow selection of schlankKO/Y larvae. By crossing with a
Cre expressing line a white− schlankKO line was established.
Generation of schlank knock in lines
The schlank target sequence (deleted genomic DNA) was cloned into the integration
vector pGE-attB-GMR. Mutations of the target sequence were introduced via muta-
genesis PCR. Vectors were injected into the white− schlankKO line by The BestGene
Inc. ϕC31 integrase dependent re-integration results in the integration of the whole
vector into the genome at the locus of the attP-site. Expression of the white gene will
lead to red eyes as a selection marker. Red eyed flies were sent and balanced over
FM7dfdeYFP. Lines were kept homozygously if possible.
3.1.5 Assays
Survival assay
For the survival assay, only male larvae were taken. Females of homozygous stocks
were crossed to FM7dfdeYFP carrying males. Eggs were collected for 4 h on apple
juice agar plates and approx. 15 larvae were sorted for the absence of the dfd-eYFP
marker 44 h AEL and transferred to a new plate. Survival and larval stage was
monitored every 24 h. Pupae were transferred to a petri dish with a filter soaked in
PBS to avoid decomposing of the slow developing schlankKI−NLS2. Experiment was
repeated 5 times.
Measuring of larval size
Larvae were transferred into PBS and heated to 60◦C for 10 minutes in a heating block.
Images were taken with a Olympus SZX binocular and larval length was measured via
CellF software.
Climbing assay
Up to 20 male flies of the analyzed genotypes were transferred into a measuring cylinder
(30 cm long) and recovered from CO2 treatment for 2 h. Flies were knocked down
and the climbing was videotaped. This was done again 5 times and experiment was
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repeated with different flies 3 times. For analysis, the video was stopped every 10 s
and walking distance of each fly was monitored.
3.2 Cell culture
3.2.1 Cell handling and transfection
Schneider cells (S2) were grown in T75 flasks in PAN Schneider’s medium supple-
mented with 10 % FCS and Pen/Strep at 25◦C and were split 1:3-1:6 when too dense.
Transfections were carried out using the reagent FectoFly (Promega) as per the man-
ufacturers instructions.
3.3 Molecular biological techniques
3.3.1 Isolation of nucleic acids
Isolation of gDNA from flies
Genomic DNA (gDNA) was isolated from single flies (Gloor et al., 1993). The fly was
anesthetized and mashed with a yellow pipet tip containing 50 µl sqishing buffer (SB)
in a microzentrifuge tube. The rest of SB was ejected and tubes were kept on 25-37◦C
for 20-30 min. Then the Proteinase K was inactivated 2 min at 95◦C. gDNA was kept
at 4◦C.
Isolation of plasmid DNA from bacteria
Analytical preparation (Mini Prep). 2 ml of LB medium containing the appro-
priate antibiotic and a master plate are inoculated with a single colony of transformed
bacteria and are incubated in over night at 37◦C with vigorous shaking. The culture
is filled into a microcentrifuge tube and centrifuged at maximum speed for 1 min.
The bacterial pellet is re-suspended in 100 µl alkaline lysis solution I, followed by the
addition of 200 µl alkaline lysis solution II and inverting 6-8 times. Then, 150 µl
of alkaline solution III are added and the mixture is inverted 6-8 times, followed by
centrifugation at 12000 g for 6 min (at 4◦C). The supernatant is transferred to a fresh
tube containing 500 µl ethanol absolute, vortexed and centrifuged at 12000 g for 6 min
(at 4◦C). The pelleteted DNA is now washed with 70 % ethanol, the pellet is dried in
the speed vac and then re-suspended in 100 µl water.
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Preparative scale (Midi Prep). For the preparative scale DNA isolation the
Nucleo Bond PC AX100 Kit from Macherey Nagel was used. 50 ml of LB medium
containing antibiotics were inoculated and culture grew o.n. at 37◦C and shaking.
Plasmid was isolated as per the manufacturers instructions and dissolved in 100-150 µl
autoclaved A.bidest and stored at -20◦C.
Isolation of RNA from tissue
For the isolation of RNA larvae or flies were collected into buffer RA1. To isolate RNA
from L1 larvae the Nucleospin RNA XS kit and to isolate RNA from L3 larvae and
adult flies the Nucleospin RNA II kit was used as per the manufacturers instructions.
Homogenization was obtained using Precellys 3x 15s 5000Upm. Beta-mercaptoethanol
was added afterwards.
Photometric estimation of DNA/RNA concentration
Concentration of DNA or RNA was measured using the nanodrop2000.
3.3.2 Polymerase chain reactions (PCR)
Genotyping and colony PCRs
Genotyping and colony PCRs were carried out using GoTaq Polymerase (Promega) as
per the manufacturers instructions. For colony PCR 25 µl master mix was provided
in the wells of a 96-well plate. With a pipet tip bacterial colonies were touched, then
a master plate was inoculated and then bacteria were transferred to the master mix
by pipetting up and down. PCRs were analyzed in agarose gel electrophoresis.
PCR for molecular cloning
PhusionTaq (Hot Start II, Thermo-Scientific) was used for the amplification of genes
that should be cloned into a vector. 4x50 µl reactions containing DMSO were pipetted
and treated as per the manufacturers instructions.
Vector mutagenesis PCR
For direct mutagenesis of plasmids (point mutations, insertions and deletions) vector
mutagenesis PCR was performed. For this, complementary missmatch primers were
used to integrate the mutations into the template during the PCR reaction. If needed,
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silent mutations resulting in a endonuclease restriction site were introduced as well.
The PCR product contains the complete plasmid sequence with the included muta-
tion(s), also in a circular nicked manner. After PCR reaction with standard reaction
conditions (Phusion Taq), the template DNA (bacterial plasmid) was digested by the
restriction enzyme DpnI, which is specific for methylated DNA for 1 h, 37◦C. Chem-
ically competent bacteria were transformed with the PCR product and incubated on
agar plates. The bacteria ligate the mutated PCR product to a circular plasmid.
For some mutations the Q5 Site-Directed Mutagenesis Kit (NEB) was used as per
the manufacturers instructions or with halved reaction volumes. With this protocol,
primers are not complementary or overlapping. The performed PCR reaction results
in a linear product that is phosphorylated and blunt-ligated in the following KLD
reaction.
Reverse transcription and real time qRT-PCR
Reverse transcription of RNA into copy DNA (cDNA) for qRT-PCR analysis was
carried out using the QuantiTect Reverse Transcription Kit (Qiagen) as per the man-
ufacturers instructions. 500 ng RNA (or as much as possible) were incubated with 1 µl
gDNA wipeout buffer in a 7 µl reaction volume 3-5 min at 37◦C. For the -RT control
1 µl of different RNA samples were pooled. Then, 2,5 µl RT-buffer/primer and 0,5 µl
RT were added (except to the -RT control) and incubated for 30 min at 42◦C followed
by 3 min at 95◦C. Then, 40 µl of water was added.
qRT-PCR was performed to analyze gene expression on mRNA level. Primer were
designed with optimums for amplicon length (120 bp), primer length (20 bp), an-
nealing temperature (59◦C) and GC-content (50 %). Primer pairs were diluted to a
concentration of 5 pmol/µl in A.bidest. Primer efficacy was tested in a dilution series
with additional test for the formation of primer dimers in a melting curve analysis.
Only primers that had an efficacy of more than 80 % were used.
Reactions were performed in duplicates or triplicates in 96-well plates in a 15 µl
reaction volume as follows:
qRT-PCR reaction
0,75 µl cDNA
6 µl A.bidest
0,75 µl Primer pair
7,5 µl SYBR-Green supermix
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The BioRad I-cycler with an IQ5 optical system was used, using fluorescence of
SYBR-Green supermix (BioRad)/DNA complexes to detect amplification of DNA
after each PCR cycle. The following program was used:
PCR-program
step 1 denaturation and initiation of polymerase 95◦C 3 min
step 2 denaturation 95◦C 10 s
step 3 annealing 50◦C 20 s
step 4 elongation 72 ◦C 15 s
45 PCR-cycles of step 2-4
Control conditions included -RT samples, where no Reverse Transcriptase was added,
and water controls. Data was calculated according to the ∆∆-CT method by the Bio-
Rad software. Expression was normalized to housekeeping genes (rp49 and actin5c)
and compared to a control condition which was set to 1. Analysis was carried out with
at least three, usually 5-7 independent biological replicates.
3.3.3 Molecular cloning
For classical cloning cDNA or gDNA was amplified via PCR using 4 reactions of
PhusionTaq. Endonuclease resitriction sites and/or small tags were inserted into the
primer sequences. Reactions were loaded on agarose gels containing SYBR Safe (In-
vitrogen) and after electrophoresis bands were excised under UV light and DNA was
extracted using Nucleospin Extract II kit. Insert was eluted in 17-43 µl A.bidest.
Vector and insert were digested using type II restriction endonucleases (NEB) in a
50 µl reaction volume (1-2 h, 37◦C) and vector backbone was dephosphorylated with
alkaline phosphatase (Roche, 20 µl reaction volume, 20 min 37◦C, then 2 min, 72◦C).
DNA fragments were ligated with T4-DNA-ligase (NEB) 1-2 h at RT. Usually, 1 µl
vector and 7 µl insert were incubated with 1 µl fresh T4-DNA-ligase buffer and 1 µl
T4-DNA-ligase.
After ligation plasmids were transformed into bacteria: 50 µl chemically competent
E.coli were thawed on ice, the ligation mixture was added and incubated on ice for
20 min. Then, a heat shock was applied (1 min, 42◦C) and after a short incubation on
ice, LB0 was added and the mixture was placed in a gently shaking heat block (37◦C,
1 h). Bacteria were grown over night on agar plates with appropriate selection media
at 37◦C.
Selection of positive clones was performed with Mini prep and enzymatic digestion of
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10 µl in a 20 µl reaction volume or colony PCR followed by agarose gel electrophoresis.
Additionally, positive clones were analyzed by sequencing by Seqlab (Göttingen).
3.4 Biochemical techniques
3.4.1 Protein biochemistry
Preparation of protein extracts
Protein extracts were prepared on ice in RIPA buffer or directly in 2xLaemmli. Ho-
mogenization was carried out either using a pistil fitting the microcentrifuge tube or
Precellys (3x 15s 5000Upm). Samples were sonicated and centrifuged. Supernatant
was transferred to a new tube and protein concentration was determined with the
BCA assay or absorbance at 280 nm.
Determination of protein concentration using BCA-reagent
Protein concentration was determined with the BCA kit from Thermo Scientific. For
few samples assay was carried out in microcentrifuge tubes (sample ad 50 µl, BCA
reagent 950 µl), for many in a 96-well plate (sample ad 10 µl, BCA reagent 200 µl).
Absorbance was measured in the Nanodrop or a plate reader, respectively. Standard
curve was always prepared in parallel with BSA in the respective buffer.
SDS-PAGE and transfer of proteins on PVDF membrane
Discontinuous sodium-dodecyl-sulfate-polyacrylamide-gel-electrophoresis (SDS-PAGE)
was used for the separation of proteins according to their molecular weight (Laemmli,
1970). Different polyacrylamide concentrations lead to different pore sizes which can
be used to efficiently separate different proteins.
Laemmli buffer was added to the samples, cooked and loaded on the gels which were
run at 20 mA/stacking gel, 25 mA/separating gel.
For antibody detection separated proteins were transferred to a PVDF membrane
via tank blotting. The PVDF membrane was activated in methanol and placed to-
gether with the gel between 3 layers of whatman paper and foam pads in transfer
buffer. The membrane was oriented to the anode, whereas the gel was oriented to the
cathode. The blotting apparatus was filled with the holder, an ice block and transfer
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component separating gel stacking gel
(2 gels, 10 %) (2 gels, 15 %) (5 %)
A.bidest 2,5 ml 3,55 ml 3,6 ml
Acrylamide (40 %) 4,8 ml 3,75 ml 630 µl
1,5 M Tris-HCl pH8,8 2,5 ml 2,5 ml -
1,0 M Tris-HCL pH6,8 - - 630 µl
10 % SDS 100 µl 100 µl 50 µl
10 % APS 100 µl 100 µl 50 µl
TEMED 10 µl 10 µl 5 µl
buffer and transfer was carried out 1 h, 100 V. Transfer was checked with PonceauS
staining.
Antibody binding and ECL detection
After the transfer of separated proteins on a membrane, the membrane was blocked
in 7 % milk powder in TBS-T for 1 h followed by incubation with primary antibodies
over night at 4◦C in TBS-T. After 3 washing steps with TBS-T the membrane was
incubated with secondary HRP conjugated antibodies 1 h at RT. After 3 more washing
steps (10 min, TBS-T, RT) detection was carried out with ECL reagent (Pierce).
Chemiluminescence was visualized on X-ray films and a curix60 developer machine.
Deglycosylation of proteins
Deglycosylation of protein in whole extracts was carried out using PNGaseF (NEB)
as per the manufacturers instructions.
3.4.2 Scanning-N-glycosylation mutagenesis
Analysis of transmembrane topology was carried out with Scanning-N-glycosylation
mutagenesis (Cheung and Reithmeier, 2007). Glycosylation sites (NST) were intro-
duced at different positions into the schlank sequence using mutagenesis PCR and the
cell culture expression vector pAc-HA-schlank. Vectors were transfected into S2 cells
in a 12-well plate and when green fuorescence was visilble in the control well (trans-
fected with pAc-GFP) after 24-72 h cells were harvested, washed and lysed in RIPA
buffer. Analysis was then performed with western blotting using the α-HA antibody.
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3.4.3 Analysis of Triacylglycerols (TAG)
Lipids were extracted from larvae with chloroform/methanol extraction. Larvae were
collected and washed in water (3-5 L3 larvae, 30-50mutant L1). They were homoge-
nized in 150 µl A.bidest using Precellys (3x 15s 5000Upm) and protein concentration
was determined with the BCA assay. 100 µl of the lowest concentrated sample were
taken and the other samples protein content was adjusted to that (in a 100 µl vol-
ume in microcentrifuge tubes). 3.75 Vol (375 µl) of chloroform/methanol 1:2 were
added, vortexed properly, then 1.25 Vol (125 µl) of chloroform was added, vortexed
and 1.25 Vol (125 µl) of A.bidest was added, vortexed and centrifuged for 1 min at
full speed. The lower phase was transferred completely to a new tube and dryed in
the SpeedVac for approx. 20 min at 45◦C. Dried lipids were dissolved in 15-20 µl
chloroform/methanol 1:1.
Thin layer chromatography (TLC) was performed using the running solvent 70:30:1
n-hexane/di-ethyl-ether/acetic acid and a HPTLC silica gel plate (Millipore). 1,5 cm
were left to sides and bottom, spacers between lanes were marked with a pencil.
Samples were added. Standards were prepared from butter or oil or commercially
available TAG etc in chloroform/methanol 1:1. After migration the plate was dried
and incubated for 10-30 s in a bath of 10 % copper sulfate and 8 % phosphoric acid (in
water). The plate was dried leaning against something and then baked in a preheated
oven (180◦C, top and bottom heating) until bands appeared well. Plates were scanned
and band intensity was analyzed using ImageJ/Fiji.
3.4.4 in vivo CerS assay/metabolic labeling of lipids
Ceramide synthase activity was determined by measuring de novo ceramide generation
after 12 h labeling of larvae with [1−14C]- acetic acid. For metabolic labeling, larvae
were fed with inactivated yeast paste containing [14C]- acetic acid (61 Ci/mol) as a C1-
precursor for lipids. Larvae were homogenized, lyophilized and weighed. Lipids were
extracted in chloroform/methanol/water (2:5:1 v/v/v). Same amounts of radioactiv-
ity of the desalted lipid extract were applied to each line on the TLC plates. Unpolar
lipids (fatty acid, triacylglycerol) were separated with n-hexane/di-ethyl-ether/glacial
acetic acid (70:30:1, v/v/v) and ceramides with chloroform/methanol/glacial acetic
acid (190:9:1, v/v/v). Radioactive bands were visualized with a Typhoon FLA 7000
(GE, Germany) and quantification was performed with the image analysis software
ImageQuantTL (GE, Germany). Lipids were identified using commercially available
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reference standards (ceramide (C18:1/C18:0) (Sigma, Germany), phytoceramide (Cos-
moferm, Delft, Netherlands), trioleoylglycerol (Sigma, Germany), and stearic acid
(Fluka)). Assay was performed in collaboration with Dr. Bernadette Breiden, AG
Sandhoff.
3.5 Stainings
3.5.1 Immunofluorescent stainings of larval fatbody
Wandering L3 larvae were ripped open in ice cold PBS either like a sardine can or
prepped inside out and directly transferred to ice cold methanol free formaldehyde
(4 % in PBS). The following fixation step was for 50-60 min at RT on a rotating
wheel. Afterwards larvae were washed several times with PBT, blocked 1 h 5 % goat
serum in PBT and incubated with first antibodies over night at 4◦C. After several
washing steps and a second blocking step for half an hour incubation with fluorescent
coupled secondary antibodies followed for 2 h at RT. Samples were washed 6x 10 min
with PBT, then fatbody was prepped and mounted in Fluoromount Dapi.
3.5.2 Toluidin blue staining of brain sections
Flies were decapitated and fixed for 20 min in 25 % glutaraldehyde in phosphate
buffer (0,1 M). After short washing steps with phosphate buffer heads were fixed in
1 % osmium/2 % glutaraldehyde for 30 min on ice in the dark and after additional
short washing steps heads were fixed in 2 % osmium 60 min on ice in the dark, followed
by short washing steps in A.bidest. After sequential dehydration to 100 % ethanol
(50,70,90,96 %, 5 min on ice each, 100 % 2x 10 min), samples were washed twice for
10 min in 100 % acetone. The eyes were equilibrated in acetone araldite solution (1:1)
at 4◦C overnight. The solution was exchanged for araldite, eyes were incubated for
more than 4 h at RT and then placed in molds and incubated at 60◦C o.n. Brains
were sectioned (1 µm), placed on slides and stained with toluidine blue stain. Samples
were rinsed in water and mounted in DePeX for imaging.
3.5.3 Imaging
Antibody stainings were imaged with the Zeiss LSM710 system. Mean staining inten-
sities were calculated for defined regions of interest in Fiji.
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3.5.4 Statistical analysis
Significance was tested using an unpaired 2-tailed Student’s t-test (Microsoft Excel)
with at least 3 independent biological replicates (n). *p<0,05, **p<0,01, ***p<0,001.
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4 Results
The aim of this study was the investigation of Schlank’s dual function in sphingolipid
biosynthesis and lipid homeostasis, and putative other roles in physiology. For this,
it’s membrane topology and glycosylation status was analyzed (section 4.1) . Also, a
schlank knock out line was generated via homologous recombination replacing large
parts of the open reading frame with an attP site. This attP site serves as a platform for
the re-integration of different schlank versions into the endogenous locus enabling us to
study the impact of specific Schlank modifications on organism function (sections 4.2-
4.3). In addition, cleavage of the Schlank protein has been observed and further
described in section 4.4.
4.1 Transmembrane topology of the Schlank protein
The Schlank homeodomain could only act as such if it faced the nuclear luminal
space and thereby is in proximity to DNA. In silico analysis using different avail-
able transmembrane (TM) topology prediction programs that use different algorithms
revealed several results, some of which are presented in figure 4.1A (Punta et al.,
2007). Therefore, experimental analysis of the Schlank TM topology was carried out
using scanning-N-glycosylation mutagenesis. This method is based on the fact that
only parts of proteins that face the lumen of the ER (and if transported to the cell
membrane the outside of the cell) are N-glycosylated. During the co-translational
process the membrane associated oligosaccharyl transferase complex transfers a pre-
formed oligosaccheride to an asparagine side chain located within the sequon (Asn-
X-(Ser/Thr)). Glycosylation sites can be introduced into the protein sequence via
cloning. The glycosylation status of the translated protein can be analyzed using
immunoblotting as glycosylation influences the moving behavior of a protein in SDS-
PAGE. Treatment of lysates with PNGaseF results in the removal of the attached
sugar residues from all N-glycosylated proteins (Cheung and Reithmeier, 2007).
For Schlank, an endogenous glycosylation site was predicted at amino acids (AA) 21,
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361 and 368 (GlycoEP). To study whether these sites are used N-terminally HA taged
Schlank protein (HA-Schlank) was over expressed in larvae using the hs-Gal4 driver
line and in S2 cells using the expression vector pAc. The Schlank full length protein
has a predicted molecular weight of approx. 47 kDa. Treatment with PNGaseF lead
to a faster moving behavior of HA-Schlank in SDS-PAGE and therefore to a band
shift. When HA-schlank was expressed that was mutated to render its glycosylation
site inactive (HA-schlankN21Q) the over expressed protein showed a similar moving
behavior as the non-mutated, deglycosylated protein and no band shift was observed
upon treatment with PNGaseF (fig. 4.1B). This data suggests a single endogenous
glycosylation site in the Schlank protein at AA 21. The prominent band at approx.
15 kDa that also showed a band shift after PNGaseF treatment of larval extracts is a
putative Schlank N-terminal cleavage product that is further analyzed in section 4.4.
For scanning-N-glycosylation mutagenesis glycosylation sites were introduced into
the Schlank protein sequence at different positions, an overview can be seen in ta-
ble 4.1. The different, HA-tagged schlank-versions were expressed in S2-cells and an-
alyzed via immunoblotting (fig. 4.1C). None of the glycosylation sites introduced into
the homeodomain resulted in a shift in band size (fig. 4.1C, lane3-4,6-12), neither the
glycosylation site introduced after the last putative TM (fig. 4.1C, lane20). However,
when the glycosylation site was introduced after the second putative TM (178NST) or
before the last putative TM (301NST) a band shift was observed (fig. 4.1C, lane13 and
18). When the endogenous glycosylation site was mutated, treatment with PNGaseF
still resulted in a band shift (fig. 4.1C, lane14,15 and 21,22). This shows, that the ar-
tificially introduced glycosylation site was recognized by the oligosaccharyl transferase
complex and that therefore, those parts of the protein face the luminal site of the ER.
Figure 4.1D shows the TM topology model based on the prediction programs but
also on the experimental data just mentioned. As those parts of the Schlank protein
around AA 21, AA 178 and AA 301 face the lumen of the ER, but most likely not
the homeodomain and probably not the very last C-terminus (around AA 348) the
Schlank protein most likely contains an uneven number of TM domains. Five TM
domains as predicted e.g. by TMHMM (I) or seven TM domains as predicted e.g. by
Phobius (II).
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Figure 4.1: Schlank topology studies. A: Predictions for Schlank TM topology using dif-
ferent programs. Numbers represent AA positions, black or gray boxes represent predicted
or putative TM domains, respectively. N in/out indicates the prediction of the localization
of the Schlank N-terminus towards the in- or outside of the cell. Results from 15 different
algorithms are shown. B: Glycosylation status of Schlank over expressed in larvae and S2
cells. Left blot shows the expression of HA-Schlank in L 3 larvae using the hs-Gal4 driver
line with and without treatment of PNGaseF, right blot shows the over expression of full
length Schlank -with and without a mutation of the predicted N-glycosylation site at AA 21-
in cell culture (pAcGal4 expression vector), Schlank full length is marked with a (*). C:
Scanning-N-glycosylation mutagenesis. Glycosylation sites have been introduced into the
Schlank sequence and moving behavior in SDS-PAGE has been analyzed. Non mutated
HA-Schlank is marked with a * (lanes 1, 5, 17). Mutation of the endogenous glycosylation
site (+-N21Q), the position of the introduced glycosylation site (GS) and PNGaseF treat-
ment (+-P.) are indicated. For the closer description of glycosylation sites introduced see
table 4.1. Lane 2: HA-SchlankN21Q; lanes 3, 4, 6-12 glycosylation sites introduced within
the homeodomain; lane 20: glycosylation site introduced after the last putative TM; lane
13: glycosylation site introduced after the second putative TM; lane 18: glycosylation site
introduced before the last putative TM; lanes 14 and 15, lane 21 and 22: additional mu-
tation of the endogenous glycosylation site. Lane 16 shows a negative control. L:lane, GS:
glycosylation site introduced, P:PNGaseF. D: TM models derived from experimental data.
Homeodomain blue, lag motif green, TM black.
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No. Mutation Position
21 N21Q, before 1st putative TM
point mutation of endogenous glycosylation site
94 K94N, in homeodomain
point mutation resulting in a glycosylation site at AA 94
130 P130N, in homeodomain
point mutation resulting in a glycosylation site at AA 130
63 63NST64, before homeodomain
introduction of a glycosylation site after AA 63
74 74NST75, in homeodomain
introduction of a glycosylation site after AA 74
84 84NST85, in homeodomain
introduction of a glycosylation site after AA 85
105 105NST106, in homeodomain
introduction of a glycosylation site after AA 105
119 119NST120, in homeodomain
introduction of a glycosylation site after AA 119
178 178NST-HA179, after putative 2nd TM
introduction of a glycosylation site and a HA-tag
after AA 178
301 301NST-NST-HA302, before putative last TM
introduction of 2 glycosylation sites and a HA-tag
after AA 301
348 348NST349, after putative last TM
introduction of a glycosylation site after AA 348
Table 4.1: Introduced mutations for scanning-N-glycosylation analysis.
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4.2 Genomic engineering of the schlank locus
The observed dual function of Schlank in sphingolipid biosynthesis and lipid home-
ostasis, it’s domain structure and it’s nuclear localization - all lead to the question of
the homeodomain function. To address domain specific functions of proteins in vivo
Huang et al. developed a method called genomic engineering /ends out gene targeting.
This method is a two step procedure where first, a knock out (KO) line is produced
via homologous recombination replacing the gene of interest with an attP site, and
second, this attP site is used for site directed re-integration of (modified) DNA (Huang
et al., 2008, 2009).
Generation of such a schlankKO line replacing large parts of the schlank gene with
an attP site followed by the generation of schlank knock in (schlankKI) lines carrying
distinct mutations within the homeodomain or the catalytic domain enables us to
study the impact of such mutations on fly physiology. Many specific mutations can be
analyzed without the artificial effects of over expression and background of wildtype
Schlank protein.
The generation of the schlankKO line was performed in cooperation with PD Dr.
Reinhard Bauer (Diploma thesis’ Luo, 2011; Peters, 2012; Bachelor thesis Hannes
Maib).
4.2.1 Genomic engineering strategy
The schlank gene is located on the X-chromosome. The endogenous locus and the
genomic engineering strategy are visualized schematically in figure 4.2. The targeted
sequence is spanning from exon 2 until the end of the 3’untranslated region (UTR).
This sequence includes all predicted functional domains of the Schlank protein; the
homeodomain is encoded by exon 2 and 3, the TLC domain is encoded by exon 3-6.
However, exon 1 including the start codon has been excluded as the first intron is
very long and contains the gene CG3781. The homologous regions (HR) flanking the
target sequence were cloned into the donor vector pGE-attP. The 5’HR is a region of
6 kb upstream of the splice acceptor site of exon2. It contains the whole open reading
frame (ORF) of the gene CG3781. The 5’HR was chosen to be comparatively long
because the 3’HR had to be shortened. A first attempt with a longer 3’HR failed due
to homozygous lethality of the flies of the produced donor line. When a 3’HR of 1,7 kb
was used that does not include the start codon of the adjacent gene spx this lethality
could be avoided. After the donor line was generated homologous recombination was
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carried out. This included three crosses as described by Huang et al. (2008) and in
section 3.1.4 leading to the exchange of the target sequence by the donor sequence (attp
site, white gene). Verification of successful homologous recombination was carried out
thoroughly and is described in section 4.2.2.
After the identified schlankKO line was crossed to a Cre-recombinase expressing line
leading to the excision of the white gene this line could be used for ϕC31 integrase
dependent re-integration of target DNA. This system is based on the bacteriophage
derived ϕC31 integrase that mediates sequence-directed recombination between a bac-
terial attachment site (attB) and a phage attachment site (attP). The target sequence
was cloned into the integration vector -where it could be easily modified- and used for
re-integration.
49
Results
Figure 4.2: Genomic engineering of the schlank locus. The schlank gene is located on the X-
chromosome (exons: green boxes) with the gene CG3781 (blue arrow) located within intron
1. 5’ and 3’ homologous regions (HR) were chosen as represented by yellow and orange bars,
respectively. The UAS reaper (black arrow) is a negative selection marker. After homologous
recombination schlank exons 2- 6 are replaced by the white gene (red arrow) and the attP
site (dark blue bar)- resulting in the schlankKO line. Crossing this line to a Cre-recombinase
expressing fly line, Cre-recombinase mediates the excision of DNA between the two loxP
sites (black bars) → schlank KO (w−). ϕC31 integrase mediates the recombination between
an attP and an attB site and can now be used for the re-integration of wildtype or mutated
schlank DNA → schlankKI , schlank KI (w+). Afterwards the donor vector backbone can be
removed by Cre-recombinase → schlank KI (w−).
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4.2.2 Verification and characterization of the schlank knock out
line
To verify the correct homologous recombination the putative schlankKO lines under-
went some verification crosses and PCR reactions. Additionally, the schlank expression
was analyzed.
First, the putative schlankKO lines were screened for lethality which results in the
absence of adult male flies with red eyes as the schlank gene is located on the X-
chromosome and lack of schlank expression leads to lethality. Additionally, if females
of a schlankKO line (schlankKO/FM7 ) were crossed to males of the P-element allele
over a duplication on the Y (schlankP (X)349/Ydp) no female flies without the balancer
but male flies with red eyes could be observed.
To further verify the schlankKO lines PCRs were carried out on isolated gDNA
(fig. 4.3A). Primer pairs were designed spanning the 3’HR or the 5’HR, always one
primer binding in the donor sequence and one primer binding outside the respective
HR. The 5’HR was too large to lead to an amplicon, but the PCR spanning the 3’HR
worked fine. To furthermore proof the lack of schlank PCRs were carried out to amplify
regions within the schlank gene. Those PCRs should only lead to an amplicon if there
is no deletion of the target sequence (fig. 4.3B). To check if the gDNA preparation was
successful a primer pair amplifying a part of the actin gene was used as a control.
To check if schlank expression was diminished qRT-PCR was carried out on RNA iso-
lated from homozygous schlankKO larvae. Analysis showed that there was no schlank
transcript left (fig. 4.3C).
De novo Ceramide synthase activity was measured in vivo by feeding radioactively
labeled acetic acid and measuring it’s incorporation into ceramide. schlankKO larvae
showed similar results as the stronger schlank mutant and de novo CerS activity was
strongly reduced as compared to white− controls. Also, incorporation into triacylglyc-
erols (TAGs) and free fatty acids (FAs) was measured and was similar in schlankKO
and schlank mutant larvae (fig. 4.3D, Bauer et al., 2009).
Taken together, those results indicate that the schlankKO line was successfully gen-
erated.
Like flies of the stronger schlank mutant allele the flies of the schlankKO line showed
severe growth defects, developmental delay and lethality in early development (fig: 4.4).
Larval length was measured 24, 48 and 72 h after egg laying (AEL). The size of control
larvae increased rapidly after hatching from the egg whereas schlankKO larvae showed
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Figure 4.3: Verification of the schlankKO line. A: Scheme of wt schlank and the schlank
locus after correct homologous recombination, primer pairs used for the verification via
PCR are shown by ⇀↽. B: PCR reactions carried out for the schlankKO line. C: qRT-PCR
analysis of schlank mRNA expression (n=6) in the schlankKO line, 43-47 hAEL. mRNA
level in white− larvae was set to 1. Significance was tested using an unpaired 2-tailed
Student’s t-test. ***p<0,001. D: Metabolic labeling of L1 larvae. Larvae were fed with
radioactively labeled acetic acid and incorporation into triacylglycerols (TAG), fatty acids
(FA) and Ceramide was measured. n=1.
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no growth (fig: 4.4A). After 72 h all schlankKO larvae were dead. Survival shows a
high similarity between the schlankKO line and the schlank mutants (fig: 4.4B).
In the qRT-PCR analysis of genes known to be regulated in schlank mutants (Bauer
et al., 2009) the same genes were up or down regulated, respectively. The transcript
level of the lipase 3 gene was significantly increased. Less significantly increased
were the transcript levels of the other tested triacylglycerol lipase brummer and the
glucagon homologue adipokinetic hormone, akh. The regulation of srebp and its tar-
get genes fas and acs was similar to their regulation in the stronger schlank mutant
allele (schlankP (X)349; Bauer et al., 2009; fig: 4.4D). Strong down regulation could be
observed in the weaker schlankP (X)61 mutant allele (Bauer et al., 2009). Overall, the
schlankKO line resembles the phenotype of the stronger schlankP (X)349 mutant allele.
Figure 4.4: Chracterization of the schlankKO line. A: Larval size of white− and schlankKO
larvae were measured 24, 48 and 72 hours after egg laying (hAEL). B: Survival of white−,
schlankP (X)349 and schlankKO larvae. C: Larvae 72 h AEL. Dyed yeast was taken up and
could be visualized in the gut. D: qRT-PCR analysis of genes known to be regulated in
schlank mutants, 43-47 hAEL (n=3-5). mRNA level in white− larvae was set to 1. Signif-
icance was tested using an unpaired 2-tailed Student’s t-test (Microsoft Excel). *p<0,05,
**p<0,01, ***p<0,001. Error bars: SEM.
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4.3 Targeted mutations to address domain specific
functions of Schlank
The established schlankKO line was used for the site specific re-integration of the
target sequence. The first step was to re-integrate the schlank wildtype sequence
(schlankKI−WT ). For the investigation of the nuclear function of Schlank two knock
in lines were generated each carrying point mutations within one of the predicted
nuclear localization signals (NLS) (schlankKI−NLS1, schlankKI−NLS2). The fly line
schlankKI−H215D was generated to analyze the phenotypes resulting from the absence
of Ceramide Synthase activity - with the Schlank protein still being there (fig. 4.5).
The fly line schlankKI−WT was generated as a proof-of-principle and can later on
serve as a control. The mutation carried by the fly line schlankKI−NLS1 is K80M/K81M
which is localized within the first nuclear localization signal resulting in the sequence
being modified from RPKK to RPMM. The second NLS is mutated from RLRR
to ALAR (R122A/R124A) in the fly line schlankKI−NLS2. The positively charged
amino acids within the NLSs (like lysine (K) and arginine (R)) are important for their
recognition and function and were exchanged to amino acids with neutral residues.
Therefore, if the predicted NLSs had a functional role in vivo less Schlank protein
should localize to the nucleus and resulting phenotypes could be linked to those point
mutations and a role of nuclear Schlank. The mutation of histidine (H) at position
215 to aspartate (D) has been reported to abolish the ceramide synthase activity
of the Schlank protein (Bauer et al., 2009). A fly line carrying this point mutation
has been generated to study the difference between a complete knock out versus a
situation where the Schlank protein is there but not the product of its enzymatic
activity (ceramide). This enables us to study the functions that result from ceramides
apart from the functions of the Schlank protein. Those functions could include a role
in lipid homeostasis as observed before in over expression studies.
4.3.1 Verification of the schlank knock in lines
To check for the correct re-integration of target DNA, gDNA was isolated from the
fly lines that showed red eye color after the procedure of ϕC31 integrase dependent
recombination. PCRs were performed as shown in figure 4.6. The PCR using primers
flanking the attR site results in a larger amplicon if the attR site is there as compared to
the wildtype sequence. The forward primer in the attL PCR is binding in the ampicillin
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Figure 4.5: Established schlank knock in lines. The re-integration of schlank DNA into
the schlankKO line was carried out with the following constructs: Wildtype schlank DNA
was used to generate the fly line schlankKI−WT . In the fly lines schlankKI−NLS1 and
schlankKI−NLS2 the schlank DNA was mutated in the predicted NLSs as indicated. A
catalytically inactive Schlank version is encoded in the schlankKI−H215D fly line.
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resistance cassette and therefore no band will be observed if the recombination didn’t
occur. All lines tested so far had a positive test outcome. Additionally, the schlank
expression was analyzed in those lines and showed wildtype mRNA and protein level.
First larval stage was chosen to avoid differences due to developmental delay. For a
quantification of the protein level the experiment has to be repeated as the number of
biological repeats were not enough.
Figure 4.6: Verification of the schlank knock in lines. A: Scheme of wt schlank and the
schlank locus after correct integration of the donor vector, primer pairs used for the verifi-
cation via PCR are shown by ⇀↽. B: PCR reactions carried out for four schlank KI lines.
schlankKI−H215D heterozygous over a balancer. C: qRT-PCR analysis of schlank mRNA
expression 43-47 hAEL (n=4-5). mRNA level in white− larvae was set to 1. Significance was
tested using an unpaired 2-tailed Student’s t-test. Error bars: SEM. D: Immunoblot analy-
sis of Schlank protein expression in the schlankKI lines 43-47 hAEL using the αSchlankCT
antibodies. Actin was used as a loading control.
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4.3.2 Basic characterization of the schlank knock in lines
Four schlank knock in lines have been generated, three of which carry distinct muta-
tions in different functional domains. To analyze those lines, first, a basic characteri-
zation was performed. The influence of the mutations on ceramide synthase activity,
survival rates, nuclear localization of the Schlank protein and on the expression of
genes known to be regulated in schlank mutants was checked.
Ceramide Synthase activity
To be able to differentiate between protein and metabolite function Ceramide Synthase
activity in the different schlank knock in lines had to be determined. De novo CerS ac-
tivity was measured in vivo by feeding radioactively labeled acetic acid and measuring
it’s incorporation into ceramide. CerS activity in schlankKI−WT and schlankKI−NLS2
was equivalent to CerS activity in white− stage 1 and stage 3 larvae, whereas the CerS
activity in schlankKI−NLS1 larvae was reduced by about 20 % in both stages (fig. 4.7).
Figure 4.7: De novo ceramide synthase activity in the schlank knock in lines. Metabolic
labeling with [14C]- acetic acid was performed with stage 1 (n=1) and 3 (n=3) larvae. Error
bars: SEM.
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Survival and development
The survival and development of the established schlank knock in lines were analyzed
and compared to white−, which is the background of the lines, and to the schlankKO
line. Like the schlankKO line the schlankKI−H215D and the schlankKI−NLS2 lines were
not homozygous viable if kept as a stock on normal fly food. For analysis, the ho-
mozygously viable fly lines (white−, schlankKI−WT and schlankKI−NLS1) were crossed
to males carrying the FM7 balancer (FM7/Y) to be able to separate male progeny for
better comparability.
white−, schlankKI−WT and schlankKI−NLS1 flies showed comparable development
and survival rates (fig, 4.8A). schlankKO and schlankKI−H215D larvae both died a few
days after hatching from the egg as stage 1 larvae. schlankKI−NLS2 flies showed devel-
opmental delay: larvae stayed approx. double the amount of time in each larval stage,
pupal stage was slightly elongated and first flies hatched after 17 days (as compared
to 9-10 days for wildtype flies). Only about 8 % of collected schlankKI−NLS2 larvae
reached adulthood whereas there was no difference between white−, schlankKI−WT and
schlankKI−NLS1 (fig. 4.8B).
Comparing the size at late first larval stage (fig. 4.8C) showed that schlankKI−WT
and schlankKI−NLS1 grow as fast as white− controls, whereas schlankKI−NLS2 larvae
were reduced in size. schlankKI−H215D larvae showed a similar size as of schlankKO
larvae, that is not much different from the size of a newly hatched larva.
Nuclear localization
The mutations of the NLSs could not be tested in flies so far as over expressed Schlank
protein doesn’t localize to the nucleus. To test the amount of nuclear SchlankNLS1 and
SchlankNLS2 as compared to SchlankWT immunofluorescent stainings were performed
using the antibodies directed against the Schlank C-terminus. Co-staining with an
anti-Lamin and an anti-Spectrin antibody helped in visualizing the outline of the
nuclei and the cells as cytoskeleton components were stained that underlie the inner
nuclear membrane (INM) or the plasma membrane (PM), respectively. Those markers
were used in the quantification to outline the areas defined as nucleus and cytosol. The
mean fluorescence intensity (MFI) of the nucleus was divided by the mean fluorescence
intensity of the cytosol and the ratios were compared between the genotypes. Antibody
specificity was tested using schlankRNAi clones (data not shown).
The MFI nucleus/MFI cytosol ratios of immunofluorescent stainings of schlankKI−WT ,
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Figure 4.8: Survival and size of the schlankKI lines. A: Hemizygous larvae of the indicated
phenotypes were collected approx. 44 h AEL. Survival was examined daily. Black arrows
show the beginning of pupariation, red arrows beginning of hatching of adult flies from pupal
cages. white−, schlankKI−WT , schlankKI−NLS1 pupariated at day 5 and nearly all hatched
at day 9. schlankKI−NLS2 larvae started pupariating at day 11 and first flies hatched at
day 17. schlankKO and schlankKI−H215D larvae died after a few days in first larval stage.
B: Amount of hatched adult flies four days after first flies hatched. schlankKI−NLS2 has
a significantly elevated lethality as compared to schlankKI−WT (p=0,0002) and to white−
(p=0,0007), Student’s t-test. Assay performed by Schwarzkopf (2015). C: Analysis of larval
size in the schlankKI lines 48 h AEL. Larvae of white−, schlankKI−NLS2 and schlankKI−H215D
are shown. Error bars: SEM.
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schlankKI−NLS1 and schlankKI−NLS2 early L3 larval fatbody are shown in figure 4.9B.
One representative picture of each genotype is shown in figure 4.9A. In schlankKI−NLS2
fatbody cells nuclear Schlank protein was reduced significantly, but not completely.
Unexpectedly, in fatbody cells of schlankKI−NLS1 larvae nuclear Schlank was enriched.
As in all pictures the same magnification was used the mean size of the cells was mea-
sured as well (fig. 4.9C). The result clearly showed that fatbody cells of schlankKI−NLS2
larvae were highly reduced in size.
Figure 4.9: Nuclear localization of Schlank in schlankKI−NLS1 and schlankKI−NLS2. A:
Immunofluorescent stainings of L3 fatbody cells using αLamin and αSpectrin antibodies
as markers for nuclear and cell membrane (green), respectively. Schlank was stained with
the αSchlankCT antibodies (red). Scale bar: 20 µm. B: Quantification of nuclear Schlank
protein. Mean fluorescent intensities (MFI) of the nucleus and the cytosol were measured (6
independent stainings, at least 10 cells each) and relative nuclear Schlank was determined.
C: Cell size was determined as well. Significance was tested using an unpaired 2-tailed
Student’s t-test. *p<0,05, **p<0,01, ***p<0,001. Error bars: SEM.
Gene expression
In schlank mutants not only sphingolipid levels are reduced but also triacylglycerol
(TAG) levels. This may be due to the up regulation of TAG lipases such as lipase 3
and brummer and the down regulation of lipogenesis factors like srebp and its target
60
4.3 Targeted mutations to address domain specific functions of Schlank
genes (e.g. fas). As the increase of TAG and lipase 3 expression upon over expression
of schlank is independent of the ceramide synthase activity it is interesting to know
how those genes are regulated in the schlank knock in lines.
RNA was isolated from L1 larvae of the different schlank knock in lines and the
expression of lipase 3, akh, brummer, srebp and fas was analyzed using qRT-PCR
(fig. 4.10). In schlankKI−WT larvae non of the genes were regulated as compared to
white− control. Expression of lipase 3 was strongly down regulated in schlankKI−NLS1
larvae but not regulated in the other schlank knock in lines. In schlankKI−H215D
larvae brummer expression was up regulated and fas expression was down regulated
in schlankKI−NLS2 larvae. Expression of srebp was not altered in any of the lines
tested.
The lack of up regulation of lipase 3 in schlankKI−H215D larvae supported the result
obtained from classical rescue experiments (sec. 6.1). There was no up regulation of
lipase 3 in schlankKI−NLS2 larvae as would be expected if the nuclear Schlank protein
was responsible for this regulation, and if the reduction of this nuclear Schlank pool
was sufficient in schlankKI−NLS2 first instar larvae. However, preliminary data on
schlankKI−NLS2 stage 3 larvae showed a strong up regulation of lipase 3 (data not
shown).
In section 4.3.3 the expression of these genes in schlankKI−H215D larvae is directly
compared to their expression in schlankKO larvae, in section 4.3.4 expression is ana-
lyzed in adult flies of the other genotypes.
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Figure 4.10: Analysis of gene expression in the schlank knock in lines. L1 larvae were
collected 43-47 h AEL and genes known to be regulated in schlank mutants were analyzed
via qRT-PCR (n=3-9). mRNA level in white− larvae was set to 1. Significance was tested
using an unpaired 2-tailed Student’s t-test. *p<0,05, **p<0,01, ***p<0,001. Error bars:
SEM.
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4.3.3 Loss of enzyme activity vs loss of complete protein
Larvae of the schlankKI−H215D line showed a similar behavior as compared to the larvae
of the schlankKO line. After hatching from the egg they did not grow, moved very
slowly and were most likely to be found on the periphery of the apple juice agar plates
whereas wildtype larvae all crawled into the yeast at the center of the plate. In both
lines the ceramide synthase activity of Schlank should be completely absent, the only
difference is the presence of the Schlank protein itself. As the additional functions of
the protein is the main topic in this thesis the two lines were compared directly in
qRT-PCR analysis and TAG-level determination.
If larval size was compared directly, there was no significant difference between
schlankKO and schlankKI−H215D larvae (fig. 4.11A).
The analysis of TAG-level was performed using thin-layer-chromatography (TLC).
Homozygous schlankKO and schlankKI−H215D larvae were collected and lipids were
extracted. Using this method no difference between the TAG content in schlankKO
and schlankKI−H215D could be observed (fig. 4.11B).
The expression of lipase 3, akh, brummer, srebp and fas was analyzed in schlankKO
and schlankKI−H215D L1 larvae. qRT-PCR analysis showed a significant lower expres-
sion of lipase 3 and brummer in schlankKI−H215D larvae (fig. 4.11C). Expression of the
other genes tested was not altered.
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Figure 4.11: Analysis of schlankKO and schlankKI−H215D. A: Larval size of schlankKO
and schlankKI−H215D larvae 43-47 h AEL, B: TAG level of schlankKO and schlankKI−H215D
larvae 43-47 h AEL was determined via lipid extraction and TLC. One representative section
of a TLC plate is shown. C: qRT-PCR analysis of the genes known to be regulated in schlank
mutants (n=4). mRNA level in white− larvae was set to 1. Significance was tested using
an unpaired 2-tailed Student’s t-test. n.s. not significant, *p<0,05, **p<0,01, ***p<0,001.
Error bars: SEM.
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4.3.4 Mutations in nuclear localization signals
Mutations of the NLSs were introduced into the schlank sequence to study their impact
on the fly organism. The fly lines schlankKI−NLS1 and schlankKI−NLS2 were generated
and their basic characterization is described above in this section (4.3). It has been
shown that in the fly line schlankKI−NLS2 indeed less nuclear Schlank was found in
fatbody cells of L3 larvae whereas in the fly line schlankKI−NLS1 the opposite is the
case. In vials schlankKI−NLS1 flies were homozygous viable and vital, schlankKI−NLS2
flies only survived to adulthood if they were separated -and then development was
retarded, many died, larvae appeared slim and larvae and flies moved less. Additionally
flies showed wing abnormalities of different kinds.
To investigate the phenotypes that arise from mutations in the Schlank NLSs in
more detail several additional experiments have been performed.
Alterations in lipid homeostasis
From previous experiments it was concluded that the homeodomain might have a
nuclear function in the transcriptional regulation of lipid homeostasis, e.g. by the
regulation of lipase 3 gene expression. As in larval stage 1 the lipid homeostasis
is just being established analysis of gene expression was also carried out in adults
(fig. 4.10, fig. 4.12A). RNA was isolated from one or five day old adult schlankKI−WT ,
schlankKI−NLS1 and schlankKI−NLS2 flies, transcribed into cDNA and analyzed via
qRT-PCR. Overall regulation of the analyzed genes (schlank, lipase 3, fas, brummer,
midway) was not much. midway was down regulated in 1 day but not 5 days old
schlankKI−NLS2 flies.
Triacylglycerol levels of schlankKI−NLS2 were analyzed in early larval stage 3 to
see the impact of the point mutation on body fat. White− larvae were taken as a
control. Due to a large developmental delay staging was carried out looking at the
mouth hooks -and collecting really early white− larvae as the content of body fat is
steadily increasing in larval stages (Carvalho et al., 2012; Guan et al., 2013). Results
of the TLC analysis are shown in figure 4.12B. As expected, TAG level were decreased
in schlankKI−NLS2 larvae. Additionally, the intensity of the band that most likely
represents free fatty acids (FA) was elevated in schlankKI−NLS2 larvae (no standard
for free FA was used).
Feeding of schlankKI−NLS2 larvae was monitored by the administration of Carmin-
red stained yeast. It was indeed taken up by the larvae and could be seen throughout
65
Results
the guts (data not shown).
The de novo rate of the formation of TAGs and FAs was addressed via metabolic
labeling with [14C]- acetic acid. Within the 12 h labeling period, schlankKI−NLS2
stage 3 larvae built up 10-15 % less TAGs than white− and schlankKI−WT controls.
In schlankKI−NLS1, stage 1 larvae and free fatty acids no change has been observed
(fig. 4.12C)
Analysis of additional phenotypes
The impression of a slower movement of schlankKI−NLS2 flies was quantified using
the negative geotaxis or climbing assay. The climbing assay is commonly used to de-
termine behavioral and neuronal dysfunction in Drosophila. 1 day old adult white−,
schlankKI−WT and schlankKI−NLS1 flies showed similar climbing ability. schlankKI−NLS2
flies however failed to climb higher than the 10 cm mark in one minute with a mean
climbing distance of 2 cm, as compared to about 15 cm (in 1 min) for flies of the other
genotypes (fig. 4.13A).
Another phenotype of the schlankKI−NLS2 line were wing abnormalities observed in
several flies hatched. Those wing abnormalities included wrinkled wings and wings
that do not abut upon the abdomen like in wildtype flies but hang down or spread
from the fly body. Examples are shown in figure 4.13B.
As such wing phenotypes are also observed in Drosophila models of Parkinson’s
disease (Greene et al., 2003), genes miss regulated there were analyzed via qRT-PCR.
Those genes are related to mitophagy. Additionally, genes involved in autophagy were
analyzed. There was no strong up or down regulation observed of any gene tested
(fig. 4.13C).
The brain morphology and apoptosis of brain cells were analyzed via toluidine blue
staining of semi-thin section of adult heads. This methodology depends on the nuclear
and cytoplasmic condensation that occurs during apoptosis (Elmore, 2007). Prelim-
inary data is visualized in figure 4.14. Vacuolization (holes) or apoptosis (dark frag-
mented nuclei) were not visualized in schlankKI−NLS2 flies, but elongated cells within
the ganglion cell layers could be observed. Overall, the schlankKI−NLS2 brains seemed
smaller/narrower and there may be a reduction of brain fatbody. This however has to
be studied in more detail.
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Figure 4.12: Mutations within the NLSs: analysis of body fat. A: qRT-PCR analysis
of 1 (n=4-10) and 5 (n=4-5) day old adult flies on genes involved in lipid homeostasis.
Adults of schlankKI−WT , schlankKI−NLS1 and schlankKI−NLS2 were analyzed. B: Triacyl-
glycerol (TAG) level of schlankKI−NLS2 (early) stage 3 larvae were compared to TAG level
of white− early stage 3 larvae via TLC. One representative lane of each genotype is shown.
C: Metabolic labeling with [14C]- acetic acid of stage 1 and 3 larvae; analysis of de novo
TAG and FA. Error bars: SEM. Significance was tested using an unpaired 2-tailed Student’s
t-test. *p<0,05, **p<0,01, ***p<0,001. Level in white− or schlankKI−WT was set to 1.
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Figure 4.13: Mutations within the NLSs: analysis of additional phenotypes. A: Climbing
assay performed with white−, schlankKI−WT , schlankKI−NLS1 and schlankKI−NLS2 flies (1
day old). Mean distance is plotted over the time. Assay performed by Schwarzkopf (2015).
B: schlankKI−NLS2 flies show wing abnormalities. Some wings are curved/wrinkled and/or
rise up or hang down from the fly thorax. Picture taken by PD. Dr. Reinhard Bauer. C:
qRT-PCR analysis of 1 day old adult flies on genes involved in mitophagy (pink1, parkin,
usp30, n=3-4) and autophagy (atg1, atg8, atg18, n=3). Error bars: SEM. Significance was
tested using an unpaired 2-tailed Student’s t-test. *p<0,05, **p<0,01, ***p<0,001. Level
in schlankKI−WT was set to 1.
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Figure 4.14: Sections of schlankKI−NLS2 adult brain. 6 day old schlankKI−NLS2 adult heads
were fixed, embedded, sliced into semi-thin sections and methylene/toluidine-blue stained.
oregonR (WT) males were taken as a control. gc: gangliar cells, fb: fatbody. Arrows point
to elongated cells that are not seen in WT brain. Preliminary data, in collaboration with
Dr. Mélisande Richard and Melanie Thielisch.
4.4 Cleavage of the Schlank protein
A cleavage of the Schlank protein was observed before the start of this thesis (PD
Dr. Reinhard Bauer, personal communication; Bachelor thesis Simon Healy). In
immunoblot analysis of larval extract with over expressed N- or C-terminally tagged
Schlank protein two specific bands were detectable: full length Schlank with a size of
approximately 47 kDa and a N-terminal fragment of about 16 kDa or a C-terminal
fragment of about 31 kDa, respectively. This cleavage could also be observed using
antibodies directed against an epitope derived from a N-terminal part of the Schlank
homeodomain (α Schlank-HOM) on wildtype larvae, and to a smaller extend when
the larvae were starved before lysis.
Back then, the following hypothesis was formulated: The homeodomain is cleaved
off from the full length Schlank protein in a feeding dependent manner, is then able to
enter the nucleus and directly or indirectly regulates genes, like e.g. lipase 3. Another
hypothesis is based on a nuclear full length Schlank protein with the homeodomain
facing the nucleoplasm, also allowing transcriptional regulation of target genes.
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4.4.1 Cleavage of the Schlank protein is observed under different
conditions
Confirmation of feeding dependent cleavage of taged and endogenous Schlank
protein
The confirmation of feeding dependent cleavage of taged and endogenous Schlank
protein is shown in figure 4.15. Representative blots are shown. The α Schlank-HOM
antibodies seemed to have a higher affinity to the smaller N-terminal fragment in
immuoblot analysis than to the full length Schlank protein as this full length band
was detected rarely. Additionally, antibodies were used directed against the Schlank
C-terminus (α Schlank-CT). α Schlank-CT antibodies detect the full length Schlank
protein and a weaker signal at about 31 kDa.
To over express N- or C-terminally HA-taged Schlank virgins of the driver line
hs Gal4 were crossed to males of the UAS-lines UAS-HA-schlank or UAS-schlank-HA,
respectively. Progeny was collected in L3 larval stage 8 hours (h) after a heat shock
of 1 h at 37◦C. Larvae were lysed and immunoblot analysis was performed using the
α HA antibody. Full length Schlank and N- and C-terminal Schlank cleavage products
could be detected (fig. 4.15A).
To analyze the feeding dependence of the Schlank cleavage white− L2 larvae were
collected and one half was starved, the other half continued feeding for 6 h. The
immunoblot analysis can be seen in figure 4.15B. In the fed condition αSchlankCT
antibodies detected a weaker signal of the size of the full length Schlank protein
(47 kDa) than in the starved condition whereas the signal at 31 kDa was stronger.
The αSchlankHOM antibodies detected a double band at about 15 kDa with both
bands being weaker in the starved condition.
Cleavage ot the Schlank protein during development
To analyze whether the cleavage of the Schlank protein is dependent on the devel-
opmental stage of Drosophila melanogaster individuals of each stage were collected
and analyzed (fig. 4.16). In embryonic and pupal stage nearly no cleavage products
were detected. In larval stages the intensity of the signal representing the smaller
N-terminal fragment decreased with age, whereas the full length signal increased. In
adults, the N-terminal fragment was detected weakly with the amount appearing more
in females.
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Figure 4.15: Confirmation of feeding dependent cleavage of taged and endogenous Schlank
protein. A: Larvae stage 3 over expressing schlank N- or C-terminally HA-taged (HA-
Schlank, Schlank-HA, respectively) under the control of the hsGal4 driver line were lysed and
expression and proteolytic processing was analyzed via immunoblotting using αHA antibody.
B: Larvae stage 2 were fed or starved for 6 h (white−). Schlank protein was detected
using αSchlankCT antibodies directed against the Schlank C-terminus and αSchlankHOM
antibodies directed against a peptide of the N-terminal part of the Schlank homeodomain.
Actin was used as a loading control. Full length Schlank 47 kDa, N-terminal fragment
16 kDa, C-terminal fragment 31 kDa.
Figure 4.16: Cleavage of the Schlank protein during development. Drosophila melanogaster
was collected in several developmental stages and immunoblot analysis was performed using
the two different α Schlank antibodies: αSchlankCT antibodies directed against the Schlank
C-terminus and αSchlankHOM antibodies directed against a peptide of the N-terminal part
of the Schlank homeodomain. Actin was used as a loading control (full length Schlank
47 kDa, N-terminal fragment 16 kDa). IB performed by Picciotto (2014).
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Organ dependent Schlank cleavage
To also analyze whether the cleavage of the Schlank protein is tissue dependent, organs
of L3 white− larvae were dissected and fatbodies, guts and brains collected in 2x
Laemmli buffer, homogenized and cooked directly (fig. 4.17). Immunoblot analysis
showed, that the smaller band recognized by the α-HOM antibodies was detected in
extracts of whole larvae and fatbody, this band slightly smaller was detected in gut
extracts as well, where also the α-CT antibodies showed the smaller band of approx.
32 kDa. In brain extract only full length Schlank was detected.
Figure 4.17: Organ dependent Schlank cleavage. Organs were dissected from larvae wan-
dering stage 3 and immunoblot analysis was performed using the two different α Schlank
antibodies. αSchlankCT antibodies were directed against the Schlank C-terminus and
αSchlankHOM antibodies were directed against a peptide of the N-terminal part of the
Schlank homeodomain. Actin was used as a loading control.
Schlank cleavage in dcerk mutants
Some mutant lines were tested in respect to Schlank cleavage as well. In Drosophila ce-
ramide kinase (dcerk)mutants (Nirala et al., 2013) cleavage appeared reduced (fig. 4.18).
Other mutants (dronc−, drice−, dcp−, srebp−, ampk−) and RNAi lines (furinRNAi,
laceRNAi) tested showed no change or unreproducible results.
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Figure 4.18: Schlank cleavage in dcerk mutants. A: Immunoblot analysis of Schlank in
white− and dcerk− larvae (44-48 h AEL; larval stage 1). One blot of two independent
biological replica is shown; (1) and (2). B: Quantification of Schlank bands relative to actin.
Full length (αSchlankCT) relative to smaller N-terminal fragment (αSchlankHOM) level in
white− larvae was set to 1, n=3. Error bars: SEM.
4.4.2 Analysis of the Schlank cleavage site
For a better understanding of the endoproteolytic processing of the Schlank protein
the cleavage site was studied.
One approach was the purification of Schlank via immuno-precipitation followed
by SDS-PAGE, Coomassie staining and mass spectrometric analysis. As the smaller
fragments are only highly abundant in larval tissue purification could not be archived
in a sufficient manner. Also establishment and addition of 2D gel electrophoresis did
not lead to a satisfying result. One Schlank peptide however could be detected from
a Coomassie stained band of the N-terminal fragment size after immuno-precipitation
of over expressed HA-Schlank using αHA-coupled columns: AANVPILEK (AA 82-
90, see fig 4.20) in collaboration with Dr. Marcus Krueger (MPI, Bad Nauheim;
Bachelor thesis Simon Healy). Additionally, in silico analysis of Schlank was carried
out in collaboration with Dagmar Stumpfe (AG Bajorath, LIMES, Bonn) but no
protease restriction site was found/conserved near the estimated site. A TPPII site
was found at AA 57, which would result in a smaller N-terminal fragment. TPPII is a
tripeptidyl peptidase that was co-purified with 26S proteasomes and may participate
in non lysosomal polypeptide degradation (Geier et al., 1999).
Here, two approaches are shown that were carried out to narrow down the Schlank
cleavage site and to establish a Schlank version that is not cleaved any more: 1st,
truncated Schlank was expressed and the size in SDS-PAGE was compared to the
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smaller fragment’s size and 2nd, schlank deletion constructs were cloned and UAS-
lines were generated as there is no cleavage observable in cell culture.
Truncated Schlank versions
Deglycosylation experiments showed, that without the attached sugar residues the
N-terminal smaller fragment behaves differently in immunoblot analysis (fig. 4.1B,
fig. 4.19). Comparing the moving behavior with the protein standard the size of the
non-glycosylated smaller fragment was about 12 kDa. This suggests a cleavage site
within the homeodomain. To get closer insight into the smaller fragment’s size trun-
cated schlank versions of different length have been cloned in a cell culture expression
vector (pAc). Cloned Schlank versions included the N-terminus until AA 98 which is
located within the first loop of the homeodomain and until AA 138 which is located
behind the homeodomain. They were HA-taged and lacking the endogenous glycosy-
lation site to avoid size differences (i.e. if the truncated versions were not transferred
into the ER and subsequently glycosylated correctly). After expression in cell culture
moving behavior was analyzed in SDS-PAGE followed by immunoblotting and com-
pared to PNGase treated extract from larvae over expressing HA-schlank (mimicking
WT).
HA-SchlankN21Q-98* showed a comparable moving behavior to the smaller N-
terminal fragment cleaved off in larvae (fig. 4.19 B). HA-SchlankN21Q-138* represents
a N-terminal fragment until the end of the homeodomain. This construct moved much
slower. To see whether a size difference of 10 AA was visible in these SDS-Page condi-
tions HA-SchlankN21Q-88* and HA-SchlankN21Q-108* were expressed and analyzed,
and indeed, the size difference to HA-SchlankN21Q-98* was clearly visible implying
that the cleavage site is close to AA 98 (fig. 4.19B).
HA-schlank1-98 and schlank99-400HA were cloned into pUAST and transgenic flies
were generated via P-element transgenesis (fig. 6.3). Those UAS-lines can be used to
over express Schlank versions that are closely related to the Schlank cleavage products.
Schlank deletion constructs
To narrow down the cleavage site and to later on establish a fly line where no cleav-
age takes place different schlank deletion constructs were cloned into pUAST and
UAS-lines were generated. First six fly-lines generated contained the schlank ORF
N-terminally HA-tagged and C-terminally Myc-tagged (HA-schlank-Myc). Deletions
introduced cover 10 AA each focussing on the hypothesis that the homeodomain might
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Figure 4.19: Truncated Schlank versions to analyze the Schlank cleavage site. A: Scheme
of Schlank and the Schlank versions expressed. AA after which a STOP(*) codon was in-
troduced are indicated. Constructs are HA-tagged and the endogenous glycosylation site is
mutated (N21Q). Blue: homeodomain, black: TM domain, green: lag motif, red: HA-tag. B:
PNGaseF treated HA-Schlank over expressing larval extract was analyzed via immunoblot-
ting and the smaller N-terminal Schlank fragment was compared to truncated Schlank ver-
sions over expressed in cell culture (88*, 98*,108*,138*; first lane on the right blot shows a
negative control: cells transfected with pAcGFP).
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be cleaved off: ∆AA119-AA128 and ∆AA129-138 at the end of the homeodomain,
∆AA139-148 and ∆AA165-174 on both sites of the second TM domain, and a puta-
tive Furine cleavage site that is the same site as NLS2 has been mutated (122RLRR to
GLRG). Furin is a proprotein convertase involved in the maturation of bone morpho-
genetic proteins like decapentalplegic (DPP; Künnapuu et al., 2009). Mutating the pu-
tative Furine site -RXK/RR- originated in an experiment where different mutant and
RNAi lines were tested on Schlank cleavage via immunoblotting using αSchlank anti-
bodies. In the furineRNAi line the amount of the N-terminal Schlank fragment seemed
less abundant. None of the ten lines each generated for UAS-HAschlankMyc∆AA119-
AA128 and UAS-HAschlankMyc∆AA165-AA174 showed expression of the transgene
(data not shown). The control (UAS-HAschlankMyc) and the three other UAS-lines
showed expression of the transgene when analyzed via immunoblotting and also the
smaller N-terminal band when the αHA antibody was used (data not shown). The
αMyc antibody for the detection of the C-terminus never gave a reliable signal.
When the size of the smaller fragment was clearer (see previous section: trun-
cated Schlank versions) new deletion constructs were cloned and five new UAS-lines
generated. N-terminal HA-tag and C-terminal GFP-tag were chosen. The following
constructs were analyzed: UAS-HAschlankGFP, UAS-HAschlankGFP∆AA89-AA98,
UAS-HAschlankGFP∆AA95-AA100 missing the loop between helix1 and helix2 of
the homedomain, UAS-HAschlankGFP∆AA101-AA109 missing the second helix and
UAS-HAschlankGFP∆AA90-AA110 missing a larger stretch of AA surrounding AA98.
Additionally a fly line was established where all the putative NLSs were mutated, in-
cluding the first stretch of the bipartite NLS2 (AA100-102, KKK) that was taken into
consideration here as well (fig. 4.20A).
All lines generated expressed the transgene and the smaller N-terminal fragment
was detected when using the αHA antibody, except for UAS-HAschlankGFP∆AA90-
AA110. There, in independent lines, the smaller N-terminal fragment was highly
reduced or even absent (fig. 4.20B). Expression however was verified as the full length
band (HA-Schlank-GFP) was detectable.
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Figure 4.20: Schlank deletion constructs. A: Scheme of Schlank deletion constructs; helices
are indicated by bold letters, NLSs are written in italic. In the Schlank full length sequence
tagged N-terminally with a HA- and C-terminally with a GFP-tag different deletions or
mutations were introduced. B: Immunoblot analysis of deletion constructs expressed in
larvae using the cg-Gal4 driver line and the αHA antibody.
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The Drosophila melanogaster Ceramide Synthase (CerS) Schlank is not only involved
in the biosynthesis of sphingolipids but also in the regulation of triacylglycerol (TAG)
levels. Second seems to be independent on the catalytic activity of the enzyme (Bauer
et al., 2009; Voelzmann, 2013).
This thesis deals with the elucidation of the Schlank non-catalytic function that
might arise from the homeodomain encoded in the Schlank sequence. It could be
shown that the homeodomain faces the cytosol which in turn means that the nuclear
Schlank protein could interact with DNA via this classical DNA-binding domain. A
schlank deficient fly line has been generated (schlankKO) that allows the re-integration
of (mutated) schlank-DNA into its endogenous locus, enabling the specific analysis of
distinct mutations. Analysis of these lines showed, that different schlank mutations
lead to different phenotypes and might even point to a Schlank function in more than
lipid homeostasis, e.g. muscle and brain function.
Additionally, the putative endoproteolytic processing of the Schlank protein has
been studied. This cleavage of a N-terminal part of the Schlank protein was observed
under different conditions, like feeding status, developmental stage, organ and mu-
tant backgrounds. The former hypothesis of the hoemeodomain being cleaved off and
translocating into the nucleus could be disproved as the cleavage site could be narrowed
down to a 20 amino acid stretch within the Schlank homeodomain (also in the mean-
while, the full length Schlank protein was shown to be nuclear in immunofluorescent
stainings; Voelzmann, 2013).
5.1 Elucidation of the non-catalytic Schlank function
A function of the Schlank protein apart from the synthesis of ceramides is mainly
observed in the regulation of lipase 3 gene expression, and also in the adjustment of
body fat. This function could arise from a direct or indirect interaction with enhancer
elements influencing expression of genes involved in lipolysis and lipogenesis as the
78
5.1 Elucidation of the non-catalytic Schlank function
homeodomain encoded in the Schlank sequence shows several features of a classical
homeodomain (sec. 1.5).
5.1.1 Schlank transmembrane topology studies prove the
nucleoplasmic orientation of the homeodomain
Until now, only few experimental evidence on CerS transmembrane (TM) topology
exists. The yeast CerS orthologs lag1p and lac1p do not contain a homeodomain
and the configuration of the lag motif remained suggestive. It most likely contains
two TM domains resulting in a total number of eight TM domains, with N- and C-
terminus facing the cytosol (Kageyama-Yahara and Riezman, 2006). Also, studies on
the homeodomain containing mouse CerS6 protein point to a cytosolic orientation of
the C-terminus, but an ER-lumenal orientation of the N-terminus (Mizutani et al.,
2005). The resultant cytosolic orientation of the homeodomain in their model is based
on predictions of a TM domain between the N-terminal glycosylation site and the
homeodomain. Some algorithms however do not predict any TM domain at this
position in the Schlank protein (fig. 4.1A).
To investigate the orientation of the Schlank homeodomain to verify it’s possi-
ble interaction with DNA in vivo, topology studies were carried out. Scanning-N-
glycosylation mutagenesis can identify protein regions facing the luminal site of the
ER. Disuse of introduced glycosylation sites can be due to cytosolic orientation of
the analyzed protein region, but also the inability of the oligosaccharyl transferase
complex to recognize the glycosylation site. Additionally, acceptor sites have to be
located a minimum distance of 12/14 amino acids (AA) away from the luminal mem-
brane surface of the ER in order to be efficiently N-glycosylated. This fact can be
used to define ends of TM domains.
The glycosylation site at the N-terminus is conserved in Schlank (AA21) and scanning-
N-glycosylation mutagenesis showed ER-luminal orientation of glycosylation sites in-
troduced after AA 178 and 301, but not at the very C-terminus or at six different
positions within the homeodomain (fig. 4.1). Additionally, two predicted glycosyla-
tion sites at the C-terminus (at AA 361 and 368) were not used in vivo. These results
strengthen the assumption of the Schlank homeodomain facing the cytosol/nucleoplasm
and the existence of the first two (at about AA 43-60, AA 141-158) and the last (at
about AA 303-328) TM domains. The N-terminus faces the lumen of the ER and
the C-terminus may face the cytosol, resulting in an uneven number of TM domains.
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Taking the algorithms into account five or seven TM domains are most likely dif-
ferentiating in the number of TM domains within the lag motif (0 vs. 2). Due to
the fact that the lag motif is involved in the catalytic activity, namely the synthe-
sis of membrane lipids, and comparison with the experimental data from the yeast
Ceramide Synthases, Schlank presumably contains seven TM domains (fig. 4.1D II).
In this model, the lag motif’s orientation within the membrane is equivalent to yeast
CerS.
As the orientation of the homeodomain would allow DNA interaction in vivo, further
studies were carried out to investigate a nuclear Schlank function.
5.1.2 Generation and establishment of schlank knock out and
schlank knock in lines resulted in a schlank null allele and
schlank alleles with restored (mutated) schlank expression
To analyze Schlank function without over expression artifacts or off-target effects
a schlankKO line was successfully established based on Huang et al. (2008, 2009).
The re-integration of schlank-DNA lead to fly lines which are expressing wildtype
schlank or schlank mutated in the homeodomain or in the catalytically important
lag1 domain under the endogenous promoter control (schlankKI−WT , schlankKI−NLS1,
schlankKI−NLS2, schlankKI−H215D, schlankKI−E118A). The fly lines were analyzed con-
cerning survival, development, gene expression, TAG level et cetera.
The basic verification showed that indeed a functional schlank null allele was gen-
erated (fig. 4.3). Minimal residual schlank mRNA and CerS activity could reside
from the maternal component(Bauer et al., 2009). The strong analogy to the stronger
schlankP (X)349 mutant allele further proves the specific deletion of schlank (fig. 4.4).
The re-integration of schlank-DNA could be proven via PCR, and the schlank
mRNA and protein expression was shown to be at wildtype level which is important
for the further characterization of those schlank knock in lines (fig. 4.6).
Analysis of Schlank protein expression in the schlank knock out and schlank knock in
lines has to be repeated with more biological replica to perform a proper quantification.
Also, protein expression has to be analyzed in respect to Schlank cleavage. The data
generated so far does not allow a reliable evaluation. The Schlank protein expressed in
schlankKI−WT larvae is processed like in white− larvae, SchlankNLS1 and SchlankNLS2
protein however have mainly been observed as full length protein (data not shown).
The peptide that was used as the epitope to generate the αSchlankHOM antibodies
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-the main tool to analyze Schlank cleavage- includes the NLS1 sequence and thus the
antibodies may not be able to bind SchlankNLS1. Over expression of Schlank with
the same point mutations within the first NLS using an UAS-line generated (UAS-
HAschlankNLS1 ) shows cleavage of the protein when analyzed with the αHA anti-
body. The mutations in the NLS2 in the UAS-lines differ from those introduced into
the schlank sequence in the schlankKI−NLS2 line (RLRR→ALAR vs. RLRR→QLQQ
(HASchlank3xNLS) and RLRR→GLRG (HASchlankMycNLS2)). Those mutations
did not change Schlank processing.
Also important for the differentiation between Schlank protein and metabolite func-
tion is the Ceramide Synthase activity of the mutated expressed Schlank proteins. This
was analyzed with an in vivo assay via metabolic labeling of larvae. The genomic
modifications performed on schlankKI−WT did not change CerS activity as compared
to white−, as well as the schlankNLS2 mutation. In schlankKI−NLS1 larvae, however,
CerS activity is reduced indicating that this mutation has an influence on the cat-
alytical activity of Schlank even though it is located within the first helix of the
homeodomain. This part of a CerS protein does not influence CerS activity in mouse
CerS5 when deleted (Mesika et al., 2007). However, considering the phenotype of
the schlankKI−NLS1 line, it indicates that a lack of 20 % CerS activity did not affect
survival and growth (fig. 4.8) as it does in schlankKO and schlankKI−H215D.
Changes in the amount of the different sphingolipids have also to be considered in
the schlank knock out and schlank knock in lines. Analysis of the sphingolipidome via
mass spectrometry is being performed in collaboration with Prof. Dr. Roger Sandhoff
(DKFZ, Heidelberg).
The schlankKI−E118A line was generated at the end of this thesis and could not be
analyzed on grounds of time. The mutation is based on a missense coding single-
nucleotide polymorphism (E115A) located in the homeodomain of the CerS2 gene
that was found in a genetic association study of rhegmatogenous retinal detachment
(Kirin et al., 2013; Park et al., 2014).
5.1.3 Schlank protein function in lipid homeostasis: comparison of
the schlankKO with the schlankKI−H215D line showed Schlank
protein dependent lipase 3 regulation
The genomic modifications carried out at the schlank locus allow the direct com-
parison of a schlank null allele (schlankKO) with an allele where the Schlank protein
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is still expressed but unable to synthesize ceramide (schlankKI−H215D, CerS activity
has to be yet determined). Therefore, the Schlank protein function can be analyzed
very specifically. Unfortunately, both lines died at first larval stage without show-
ing any growth, similar to schlankP (X)349 mutants (fig. 4.4A-C, 4.8A,C, 4.11A). Even
though this underlines the importance for ceramide biosynthesis on survival, it also
complicates experimental analysis. Measuring TAG level using TLC did not show any
differences between the two lines (fig. 4.11B). Stage 1 larvae however do not have much
TAG in general and a more sensitive method (like mass spectrometry) could be suited
better (Carvalho et al., 2012). Differences in TAG level between schlankKI−H215D
and schlankKO larvae are supposed as qRT-PCR analysis showed no up regulation
of lipase 3 in schlankKI−H215D larvae as it is seen in schlankKO and schlank mutant
larvae (fig. 4.4D, 4.10, 4.11C). Also, brummer may not be as highly up regulated
in schlankKI−H215D larvae as in schlankKO larvae, whereas akh, srebp and fas show a
similar regulation (fig. 4.11C). The differences in the expression of those lipases may
result in modified TAG level and point to the regulation of those genes, especially
lipase 3, by the Schlank protein and not the ceramide level. On the other hand, the
similar regulation of akh and fas may point to their regulation via ceramide level.
5.1.4 Schlank function in the nucleus: mutations in the NLSs
result in a variety of phenotypes affecting lipid homeostasis
and behavior
Schlank full length protein was detected in the nucleus and it’s import could be linked
to Ketel (fly homologue of Importin-β) and two putative NLSs. Schlank Homeodomain
- DNA interaction was shown in vitro and gene regulation was studied using over ex-
pression of deletion constructs (Voelzmann, 2013). Here, in vivo function of nuclear
Schlank protein pools was addressed using the schlank knock in lines carrying muta-
tions within those two NLSs: schlankKI−NLS1 and schlankKI−NLS2.
The point mutations within the NLSs where chosen to get an insight what the
nuclear function of the Schlank protein may be. Nuclear localization of mutated
Schlank was changed, indeed, but as the NLSs are localized within the homeodomain
also a putative unknown function may be affected. For example, some homeodomains
are required for dimer formation (Papadopoulos et al., 2012) and the third helix which
contains the second NLS is important for the sequence specific interaction with DNA
(Gehring et al., 1994b). In this case, additional effects of the mutations are not known
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and therefore need to be studied in more detail. It was shown that mammalian CerS
dimerize which affects their CerS activity (Laviad et al., 2012).
As over expressed full length Schlank protein is not found in the nucleus in im-
munoflourescent stainings, first, the nuclear localization of SchlankNLS1 and SchlankNLS2
was analyzed to see whether those mutations lead to a disrupted translocation of
Schlank into the nucleus, as would be consistent with cell culture experiments with
homeodomain constructs obtained by Voelzmann (2013). Indeed, SchlankNLS2 showed
a weaker, but not absent, nuclear localization as compared to SchlankWT . Unexpect-
edly, SchlankNLS1 showed a stronger nuclear accumulation (fig. 4.9A+B). The reason
of an only partial reduction of nuclear SchlankNLS2 could be grounded in the two NLSs
working together. Therefore, the functional NLS1 could be responsible for the smaller
amount of nuclear SchlankNLS2. The accumulation of SchlankNLS1 in the nucleus could
be based e.g. on the specific mutation used or disrupted nuclear export signals (NES).
Predicted NES do not overlap with the NLS1 (Kosugi et al., 2008; Munsie et al., 2012)
and the deletion of the first NLS (RPKK) in homeodomain constructs resulted in it’s
weaker nuclear accumulation in cell culture experiments. In those experiments, mu-
tations in both NLSs (R78A R124A) also reduced nuclear accumulation (Voelzmann,
2013). Here, the NLS1 was mutated to RPMM, because it is followed by two alanine
residues and a deletion was considered too invasive.
Schlank homeodomain function in lipid metabolism
Nuclear Schlank accumulation in stage 3 schlankKI−NLS1 larvae could explain the down
regulation of lipase 3 mRNA in schlankKI−NLS1 L1 larvae (fig. 4.10). Analysis of TAG
level could help figure out if this regulation results in a physiological change. De novo
TAG and FA synthesis in schlankKI−NLS1 larvae showed no change (fig. 4.12C). Devel-
opment of schlankKI−NLS1 flies was unchanged as compared to the controls (fig. 4.8).
Unfortunately, de novo CerS activity was reduced by 20 % in this line in first and
third instar larvae.
On the other hand, flies carrying the mutation within the second NLS showed un-
changed CerS activity, but severe phenotypes. Analysis revealed a delayed develop-
ment, lethality of about 90 % until adulthood and growth defects (fig. 4.8). In stage 1
larvae fas mRNA was down regulated (fig. 4.10), and preliminary data on stage 3
larvae showed a strong up regulation of lipase 3 transcript level (data not shown).
fas down and lipase 3 up regulation is consistent with gene expression in schlankKO
larvae (fig. 4.4D) and would fit the hypothesis of this gene regulation via the Schlank
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homeodomain.
The transfer of this qRT-PCR data on physiological level is observed in a reduced
size of fatbody cells, decreased TAG level in stage 3 schlankKI−NLS2 larvae and reduced
de novo TAG synthesis (fig. 4.9C, fig. 4.12B+C). This data strengthens the hypothesis
of the (nuclear) Schlank protein being involved in lipid homeostasis.
The qRT-PCR experiments on third instar larvae has to be repeated to confirm the
lipase 3 up regulation in the stage where the body fat phenotype is most obvious.
lipase 3 expression was not up regulated in first instar larvae and adult flies of the
genotype schlankKI−NLS2. The reason may be that the described expression of this
gene is restricted to larval fatbody and that feeding behavior is changed from con-
tinuous feeding in larval stages to on-off feeding in adult stage (Pistillo et al., 1998).
A gene regulated in adult flies is the AkhR target midway (Baumbach et al., 2014),
which is down regulated in one day old schlankKI−NLS2 flies. It encodes the Drosophila
Diacylglycerol O-Acyltransferase 1 and mutants have a lean phenotype (Beller et al.,
2010).
Reduced TAG level, up regulated lipases and down regulated lipogenesis factors can
also be due to starvation or the inability to take up food. schlankKI−NLS2 larvae took
up red dyed yeast that was visible throughout the gut which shows, that they feed
and the food gets along through the intestinal tract. Also, the metabolic labeling
experiments showed that the larvae indeed took up the radioactivity. To further check
for starvation one could check the activity of the insuline pathway e.g. via qRT-PCR
of target genes (InR) or FOXO localization.
Total FAs seemed to be elevated in schlankKI−NLS2 stage 3 larvae, but de novo
FA synthesis was unchanged (fig. 4.12B+C). Therefore, FAs may result from elevated
lipolysis. As both, total and de novo TAG level were reduced, thus may result from
reduced synthesis, but TAG decomposition could be involved as well.
Looking at fas transcriptional regulation in the lines analyzed here, it may either
be influenced by the homeodomain (as just mentioned) or by ceramide synthesis (as
assumed by comparison of schlankKO with schlankKI−H215D). Repetition of this anal-
ysis to reduce error bars may give clarity, as fas expression shows a tendency to be
down, or up regulated in schlankKI−H215D larvae as compared to white− or schlankKO
larvae, respectively, hinting to a regulation via the Schlank homeodomain. Including
other lipogenesis genes may be worthwhile, also including stage 3 larvae as in that
stage FAs seemed to be elevated in schlankKI−NLS2 animals.
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Additional phenotypes observed in the schlankKI−NLS2 fly line may link the
Schlank homeodomain to muscular and neuronal function
The main aspect in this theory is the impaired moving behavior of schlankKI−NLS2
flies. Quantification of this was achieved using the negative geotaxis (or climbing)
assay commonly used to determine behavioral and neuronal dysfunction in Drosophila
melanogaster. It can reflect ataxia that is common in human neurodegenerative dis-
eases. A disadvantage of this method is that loss of climbing can be due to factors
other than neurodegeneration (Lessing and Bonini, 2009). In comparison to white−,
schlankKI−WT and also schlankKI−NLS1 flies schlankKI−NLS2 flies showed a strong re-
duction of climbing distance (fig. 4.13A). Further analysis in this direction were qRT-
PCR analysis and analysis of brain and muscle structure of adult flies. Due to ab-
normal wing posture in schlankKI−NLS2 flies that were also observed in fly models of
Parkinson’s disease (Greene et al., 2003; Yang et al., 2006; Fernandes and Rao, 2011)
gene expression of pink, parkin and usp30, but also of autophagy genes (atg1, atg8,
atg18 ) was analyzed to get a first impression (fig. 4.13B+C).
Similar wing posture phenotypes were also observed e.g. in another model of mi-
tochondria unfolded protein response (UPRmt; Pimenta de Castro et al., 2012), upon
impairment of the ubiquitin pathway (Liu and Pfleger, 2013), in a Drosophila model for
oculopharyngeal muscular dystrophy (OPMD; Chartier et al., 2006) and amyotrophic
lateral sclerosis (ALS; Sanhueza et al., 2014). All those models are associated with
an accumulation of proteins in different organelles, leading to dysfunction or degener-
ation of muscle cells and/or neurons, further suggesting an impact of SchlankNLS2 on
muscle and neuron function. About 80 % of the few flies of the schlankP (X)61 mutants
that reach adulthood fail to deflate their wings after eclosion, rest 20 % show partially
or fully deflated wings, which then also show the same wing posture defects (André
Voelzmann, unpublished data).
Schlank knock down specifically in glial cells, but not in neurons, was shown to
disrupt axonal ensheathment (Ghosh et al., 2013). Axonal ensheathment is important
for motor function and survival and as it was shown to be impaired in schlank RNAi it
may also be affected in the schlankKI−NLS2 fly line. Until now, the axonal phenotype
observed is discussed as a result of reduced PE-ceramide, as it also appears in lace,
spt-1 and des1 RNAi in all of which PE-ceramide has been shown to be reduced
(Ghosh et al., 2013).
Wing muscle structure in schlankKI−NLS2 flies seemed normal when dissected and
stained with phalloidin (Yanina Pesch, personal communication) suggesting that im-
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paired moving is not due to apparent muscle damage. However, closer analysis of
the muscles via microscopy e.g. with a higher resolution and specific stainings and
via functional assays is necessary. This would help unravel the mechanistic back-
ground of the impaired climbing assay performance and wing posture defects of the
schlankKI−NLS2 flies.
Parkinson’s disease is a neurological disorder linked to aberrant protein folding, ox-
idative damage and mitochondrial dysfunction with the progressive loss of dopaminer-
gic neurons in the substantia nigra of the midbrain, but also others (Spillantini et al.,
1997; Dauer and Przedborski, 2003; Braak et al., 2003; Hirth, 2010). It has also been
linked to CerS (Abbott et al., 2014). Among the genes affected in familial forms of
Parkinson’s disease are parkin and the tensin homologue (PTEN)-induced kinase I
(pink1). parkin encodes a protein with E3 ubiquitin ligase activity, pink1 a protein
with a serine-threonine kinase domain and a mitochondrial targeting sequence. PINK1
and Parkin act in a linear pathway to regulate mitochondrial integrity and mainte-
nance, probably as mediators of the mitochondrial fission machinery (Guo, 2012). The
recruitment of Parkin to mitochondria depends on PINK1 and PINK1 protein level
are up regulated on damaged mitochondria (Narendra et al., 2008, 2009; Vives-Bauza
et al., 2010; Ziviani et al., 2010). parkin has been shown to be regulated also on
transcript level, e.g. by ATF4, a UPR activated transcription factor, whereas PINK1
protein level seems to be regulated mainly in a posttranslational manner (Imai, 2012).
USP30, a deubiquitinase localized to mitochondria, has been shown to be an antagonist
of PINK1 and Parkin dependent mitophagy (Bingol et al., 2014). In schlankKI−NLS2
flies parkin and usp30 are slightly up regulated. As they are antagonists and the reg-
ulation is very weak this may not have a strong physiological effect. To check directly
for UPRmt activation hsp-60 and hsc-70-5 mRNA level could be analyzed.
Also, autophagy associated gene expression is not highly altered in schlankKI−NLS1
and schlankKI−NLS2 flies, the latter showing a slight tendency towards up regulation of
atg1 and atg18. Autophagy is a mechanism to recycle unnecessary or dysfunctional cel-
lular components through the actions of lysosomes. It is required for normal turnover
and is also observed in cancer and in response to nutritional starvation (Mortimore and
Pösö, 1987; Mathew et al., 2007; Mizushima et al., 2004). Autophagy associated genes
like atg1, atg8, atg18 are transcriptionally up regulated upon autophagy induction,
but as this regulation is not studied in detail and do not always need to be significant
other methods should be performed as well (Klionsky et al., 2012).
Investigation of brain morphology was performed with the help of toluidine blue
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staining of brain sections. This data is preliminary as it was only performed once, with
the age of the control flies being unknown. Those experiments suggest a reduced size
of brains of schlankKI−NLS2 flies. Also, elongated cells have been observed that were
present only in schlankKI−NLS2 but not in control brains. Apoptosis and vacuolization
could not be observed (fig. 4.14). As the elongated cells do not appear darker than
surrounding cells they are probably not apoptotic. They may have evolved from brain
cells or could be immune or other cells invasing the brain.
Experiments to shed light on the brain function in schlankKI−NLS2 flies -among the
repetition of the toluidine stainings- could be transmission electron microscopy (TEM)
which allows better resolution of sub-cellular structures and electrophysiology which
allows the direct assay of neuronal dysfunction. Also, a closer analysis of the life span
could help because all neurodegenerative mutants show a shortened lifespan (Lessing
and Bonini, 2009).
Lipid homeostasis and muscle/brain function
Taken together, the climbing assay performance, the abnormal wing posture and
the possibly reduced brain size of schlankKI−NLS2 flies point to an influence of the
schlankNLS2 mutation on neuronal and maybe muscular function. Expression analysis
of schlank showed it’s abundance in neurons and neuroblasts (Voelzmann and Bauer,
2011; Voelzmann, 2013). The precise phenotype and the underlying mechanisms how-
ever have to be studied in more detail.
It is possible that those phenotypes are grounded in the reduced TAG-level in stage 3
larvae and a resulting energy deficit in neurons and muscles. Measuring ATP level
may help figuring out their energy status.
Yet, not much is known about how lipid and energy homeostasis influence neurode-
generative phenotypes, but some neurodegeneration Drosophila mutants have been
linked to lipid homeostasis (Liu and Huang, 2013). For instance, mutants of two
genes involved in the de novo Coenzyme (Co) A biosynthesis (fumble and phosphopan-
tothenoylcysteine synthetase), and of the fatty acid CoA ligase bubblegum specific for
very long chain FAs develop neurodegeneration phenotypes (Yang et al., 2005; Bosveld
et al., 2008; Min and Benzer, 1999). Apolipoprotein D (ApoD), a lipid carrier res-
cues in Alzheimer’s disease and Friedreich’s ataxia (Muffat et al., 2008; Navarro et al.,
2010). Lessing and Bonini (2009) surveyed genes causing adult onset neurodegenera-
tion in the fly and classified them according to five key cell biological processes. They
have listed e.g. the F1F0-ATP synthase subunit and the Na+/K+ ATPase α subunit.
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Mammalian Ceramide Synthase 2 was shown to interact with vacuolar ATPase via
it’s homeodomain, thereby modulating V-ATPase activity (Yu et al., 2013). SREBP
was shown to link lipogenesis with mitophagy in a genome wide RNAi screen (Ivatt
et al., 2014; Ivatt and Whitworth, 2014). Also, there is a close connection between
metabolic status and the reactivation of neuroblasts from quiescence, where Target
Of Rapamycin (TOR) and Insuline-like Receptor signaling are involved (Sousa-Nunes
et al., 2011).
Subramanian et al. (2013) showed in another context, that climbing assay perfor-
mance was decreased in flies that were starved and therefore had reduced TAG level.
The underlying mechanism by which the different mutations and conditions influence
neuronal function are not yet understood.
Another factor to consider is the Ceramide Synthase activity of SchlankNLS2 in
the nucleus. If the nuclear CerS activity is important for different processes like cell
division or epigenetics (like Sphingosine Kinase; Hait et al., 2009) and is reduced in
the schlankKI−NLS2 line this could be responsible for some phenotypes.
Nevertheless, in this study it could be shown that point mutations within the third
helix of the Schlank homeodomain influencing nuclear localization and maybe other
interactions, but not overall CerS activity was responsible for a broad range of phe-
notypes.
Individuals of the schlankKI−NLS2 line showed similar phenotypes as compared to
the schlank mutant alleles, especially the weaker schlankP (X)61 allele (lean, reduced
TAG, less moving, stay outside yeast paste, wing posture). The phenotypes observed
in schlank mutants are more severe and may result from a combination of protein
functions. The mutation in the second NLS could explain some of the mutant pheno-
types.
Lately, mammalian CerS6 was reported to regulate acid ceramidase gene expression
in a CerS6 activity independent manner (Tirodkar et al., 2015) which could hint to a
conserved function of CerS homeodomains.
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5.2 Schlank endoproteolytic processing
Cleavage of proteins is not only a degradative event, but also involved in signaling
pathways as a regulatory mechanism (Ehrmann and Clausen, 2004). To analyze the
putative cleavage of the Schlank protein -which is observed as N- and C-terminal
fragment bands in immunoblot analysis- several experiments have been performed to
narrow down the site of cleavage and to get an insight into the regulation of this event
(sec 4.4).
InDrosophila melanogaster there are 585 known and putative peptidases (MEROPS,
Rawlings et al., 2014).
5.2.1 Schlank is split within the homeodomain
Analysis of the Schlank cleavage products revealed that the site of endoproteolytic
processing would be within a 10 AA range from AA98 in both directions (fig. 4.19).
Studies with HA-Schlank-GFP over expression lines with deletions and mutations
within the homeodomain further showed, that deletions of AA 89-98, AA 95-100 and
AA 101-109 still resulted in cleaved Schlank protein expression, whereas deletion of
a larger stretch spanning this area (AA 90-110) resulted in way less cleavage product
(fig. 4.20). N-terminal of this area a Schlank peptide was found in MS analysis of
the smaller fragment band (AA 82-90) and in the HA-Schlank construct with all NLS
mutated (78-81RPKK→QPQQ, 100-102KKK→EEE, 122-125RLRR→QLQQ) -which
is also still cleaved- the mutation of AA 100-102 overlaps the deletions of AA 95-
100 and AA 101-109. Unexpectedly, all deletion constructs showed the same moving
behavior in SDS-PAGE, even after deglycosylation (fig. 4.20). The deletion of the
10 AA 89-98 which are most likely N-terminal of the cleavage site should result in a
smaller band as observed for HA-Schlank88*.
Those results show that the Schlank protein is processed within the homeodomain.
It remains unclear whether this event occurs via one site specific protease because
overlapping deletion and mutation of smaller stretches of AA ranging from AA 89 to
AA 109 still result in cleaved Schlank protein, with size comparisons suggesting a site
within this protein region. It could be possible that the recognition site of the protease
is not it’s cleavage site: It may recognize an AA sequence up- (or down-) stream which
is not affected by the deletions and cleave at about AA 98. HASchlankGFP∆90-110
might not be cleaved due to misfolding and/or interfering 3D structure. Another
explanation could be the existence of two sites; one at AA 110 and a second one
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leading to the truncation of the N-terminal fragment.
Altogether it seems unlikely that the observed Schlank processing may be due to
an experimental artifact as there are conditions observed where there is no Schlank
cleavage (e.g. pupal stage, starvation) and fragment bands can be detected with
different antibodies.
Now, that experiments showed that cleavage is most prominent in stage 1 larvae
(fig. 4.16), one could consider repeating MS analysis of the N-terminal fragment with
extracts from this stage instead of extracts from 3rd instar larvae, to investigate the
site of cleavage.
5.2.2 Different conditions affect Schlank processing
The amount of Schlank fragments varied under different conditions like developmental
stage, feeding condition and organ (section 4.4.1). It could be observed that with ris-
ing larval stage the smaller N-terminal fragment level decreases whereas the amount of
full length protein increases. In embryo and pupal stage nearly no smaller N-terminal
fragment could be detected, but a high amount of full length protein (fig. 4.16). In
larvae, the deprivation of food resulted in a reduction of the smaller N-terminal frag-
ment and an increase of full length Schlank protein; in stage 1 and stage 2 larvae this
occurred quiet rapidly after 3-6 h of starvation, in stage 3 larvae a starvation period
over night was necessary (fig. 4.15). To identify the organ in which this event hap-
pens, stage 3 larvae where dissected showing few N-terminal fragment in fatbody and
gut, but none in brain extracts (fig. 4.17). Another indication of cleavage occurring
in fatbody cells is the appearance of fragment bands of tagged Schlank protein over
expressed under the control of the cgGal4 driver line (fig. 4.20B). The analysis of differ-
ent mutant larvae showed less Schlank cleavage in Drosophila ceramide kinase (dcerk)
mutants (fig. 4.18). In dcerk mutants ceramide is accumulated, ceramide-1-phosphate
levels seem unchanged in whole fly extracts and metabolism is reprogrammed, proba-
bly through the enhanced activation of Akt and following inhibition of FOXO (Nirala
et al., 2013). As under starvation Akt phosphorylation is decreased and FOXO is ac-
tivated (Calnan and Brunet, 2008), but Schlank cleavage is also reduced, a regulation
via this mechanism seems unlikely.
Looking at commonalities of those conditions, Schlank cleavage may correlate with
TAG level. TAG level are reduced under starvation, elevate during larval stages, are
lower in males than in females, high in fatbody and low in brain. Also, in dcerk
mutants they are decreased (Palanker et al., 2009; Carvalho et al., 2012; Guan et al.,
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2013; Nirala et al., 2013). If this correlation was causative, it would still be unclear
whether Schlank cleavage occurs up- or downstream of body fat regulation. Due to the
hypothesized direct or indirect binding of the Schlank homeodomain to the lipase 3
enhancer region cleavage may regulate this interaction. Therefore, the protease had to
be nuclear. Aspects in the disfavor of this hypothesis are the non-nuclear localization
of over expressed schlank in immunofluorescent stainings (but over expressed Schlank
being cleaved) and no lipase 3 regulation in dcerk mutants (microarray analysis, Nirala
et al., 2013). For now, it is unclear, in which subcellular compartment cleavage occurs.
An impact of Schlank cleavage on Ceramide Synthase activity is also imaginable as
cleavage may result in an inactive protein. Especially since the endogenous C-terminal
fragment shows a low abundance using the αSchlankCT antibodies. If the Schlank
full length band would correlate with CerS activity high activity would be expected
in embryo, pupae, brain, in dcerk mutants and under starvation, but not in well
fed larvae. The Ceramide Synthase activity of the Schlank protein has not yet been
analyzed under the conditions mentioned above. Additionally, establishment of an in
vitro NBD-CerS assay (Kim et al., 2012) for Drosophila showed an inhibition of the
reaction by the addition of AcylCoAs of different chain length and could therefore not
be used. The in vivo CerS assay could not be used to compare fed with starved larvae
as uptake of radioactively labeled substrate is achieved via feeding. Looking at the
ceramide level during development may be an alternative, but one has to keep in mind,
that ceramide is further metabolized to other sphingolipids and that ceramide can be
generated via three different pathways. Ceramide level may therefore not represent it’s
de novo synthesis. Ceramide level highly increase in embryonic stage and decrease in
larval stages when normalized to total membrane lipids measured (Guan et al., 2013).
If normalized to individuals they more or less increase during larval stages (Carvalho
et al., 2012). Both normalization methods show a relatively constant ceramide level
during pupal stage. In the brain, cermaide level are comparably high. In dcerk mutants
ceramide level are elevated due to the loss of ceramide kinase (Nirala et al., 2013). One
would assume that CerS activity is needed in the state of drastic growth as observed
in larvae and that upon ceramide accumulation like in dcerk mutants CerS activity
would be decreased.
Many regulative protease events result in a localization change, which could be pos-
sible here as well. However, experimentally, this is not easy to achieve, yet. Schlank
localization is very broad and not all Schlank pools have been assigned, Schlank over
expression does not resemble the endogenous Schlank localization and co-stainings us-
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ing the αSchlankHOM and the αSchlankCT antibodies to stain the N- or C-terminus,
respectively, are difficult as the αSchlankHOM antibodies do not work well in stain-
ings.
It is also yet to find out whether the UAS lines HA-schlank1-98 and schlank99-
400HA functionally resemble the Schlank cleavage products or not.
Taken together, Schlank endoproteolytic processing seems to occur within he home-
odomain and in a regulated manner. Further investigation could unravel new mecha-
nisms of Schlank function.
The hypothesis of the Schlank homeodomain being cleaved off to then enter the
nucleus could be disproved. The small size of the non glycosylated N-terminal Schlank
fragment (fig. 4.1B) and the studies on the cleavage site (fig. 4.19+ 4.20) showed a
disruption of the heomeodomain by this processing event. The alternative hypothesis
of a full length nuclear Schlank protein has gained more relevance. It is also supported
by the immunofluorescent stainings using antibodies directed against the Schlank C-
terminus showing nuclear Schlank protein (Voelzmann, 2013; see also fig. 4.9A).
5.3 Outlook
In the future, the further experiments mentioned in the respective sections could
help get better insight into Schlank nuclear and protein function, and also into the
mechanisms underlying Schlank cleavage. Especially important is e.g. the lipidomic
analysis of the schlank knock out and schlank knock in lines generated, because the
differentiation between protein and metabolite function is crucial.
Additionally, to investigate the impact of lipase 3 regulation on body fat, analysis of
lipase 3 repression and over expression in respect to TAG level should be performed,
preferably in different schlank backgrounds. Not much is known about the quanti-
tative correlation between lipase 3 gene expression and TAG level. In cell culture
experiments, schlank dsRNA mediated reduced TAG level could be rescued by lipase3
RNAi (Ute Schepers, unpublished data; André Voelzmann, personal communication).
Microarray/RNAseq and MS studies on schlankKI−NLS2 as compared to schlankKI−WT
and schlankKI−H215D as compared to schlankKO would help get a better overview on
changes in the gene regulation and the lipidome of those lines. This is advantageous
to find out e.g. the genes differentially regulated due to the (catalytically inactive)
Schlank proteins presence and may help finding new Schlank target genes. Using those
lines will minimize false positive regulations that might arise e.g. from over expression
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artifacts (Liu and Lehmann, 2008). Also different methods that are commonly used
to identify transcription factor function, like chomatin-IP and luziferase assays, may
be useful. Several assays performed link the Schlank homeodomain to transcriptional
regulation via direct or indirect binding to DNA, like the yeast-1-hybrid assay per-
formed by Noyes et al. (2008), electromobility shift assays performed by Voelzmann
(2013) and luciferase assays (Voelzmann et al., 2015).
New schlank knock in lines could be established. The schlankNLS2 mutation is very
elegant and small, but the influences on different aspects of the protein than nuclear
localization are rather unclear. A deletion of a large part of the homeodomain -that
does not affect CerS activity- may be beneficial in order to analyze the "complete"
homeodomain function. This however can have more secondary effects on protein
structure and on constraints within the TM domains. Mutations in both parts of the
bipartite NLS2 could further reduce nuclear Schlank protein. Also, a schlank knock
in line with impaired cleavage could be interesting, but therefore a smaller mutation
than the deletion of AA 90-110 would be preferable. Additionally, also this mutation
may lie within the homeodomain and additional unforeseeable influences could arise.
Another interesting perspective could be the generation of a conditional schlankKO
line that would allow analysis of Schlank function in a tissue dependent manner.
Until now, nuclear Schlank protein has been mainly studied in the larval fatbody.
Also, Schlank cleavage has been described in this organ. Analyzing different organs like
e.g. the brain may be interesting to study the interplay between those two phenomena.
93
Discussion
5.4 Conclusions and working model
The Drosophila melanogaster Schlank protein is involved in ceramide biosynthesis, but
also lipid homeostasis (Bauer et al., 2009; Voelzmann, 2013). This thesis dealt with
the further characterization of the Schlank protein function independent of Ceramide
Synthase activity. In this matter, several key points were addressed:
– A schlankKO line generated via homologous recombination showed strong similar-
ity to the schlank P-element mutants, further supporting the formerly described
schlank deficiency phenotypes like reduced ceramide and TAG level, lethality,
growth defects and lipase 3 up regulation.
– The re-integration of target DNA into the schlankKO locus could be established
and five schlank knock in lines were generated. This method allowed the integra-
tion of specific mutations into the schlank sequence enabling the direct analysis
of those mutation’s impact, without over expression and background artifacts.
Re-integration of target DNA carrying a mutation that results in a catalytically
inactive Schlank protein proved the lipase 3 transcriptional regulation via the
Schlank protein, independent of CerS activity. Mutations affecting the puta-
tive NLSs showed different results. Mutations in the first NLS unexpectedly
increased nuclear Schlank protein, suggesting that this putative NLS does not
act as such in vivo or that the mutation introduced has no inhibiting effect. Mu-
tations in the second putative NLS reduced nuclear Schlank protein by about
10 %, without affecting Schlank expression level and CerS activity. This points
to a functionality of the second NLS in vivo. Interestingly, phenotypes observed
in this schlankKI−NLS2 line, some of which have been also observed in schlank
P-element mutants, link this mutation to lipid homeostasis, motility and growth,
and maybe brain/muscle function. The reduced TAG level strongly support the
theory of the Schlank homeodomain being involved in lipid homeostasis; in this
case via a mutation within this domain that influences nuclear localization but
may also influence DNA and/or protein interactions as it is localized in the third
helix.
– Glycosylation experiments showed a single conserved endogenous glycosylation
site at AA 21. Scanning-N-glycosylation mutagenesis experimentally strongly
supports the cytosolic/nucleoplasmic orientation of the homeodomain within the
full length Schlank protein and revealed a TM domain structure of supposedly
7 TM domains.
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– Cleavage of the Schlank protein has been proposed as Schlank fragment bands
were observed in immunoblot analysis using different antibodies. This cleavage
was shown to occur in larval stages under good feeding conditions, in the fatbody
and other organs. It was rather absent under starvation, in embryonic and pupal
stage and in the larval brain. Also, in ceramide kinase (dcerk) mutants less
fragment band was detected. The site of cleavage was narrowed down to a 20 AA
stretch within the Schlank homeodomain. As the Schlank fragment bands were
detected to a different extend under different conditions a regulated reasonable
cleavage of the Schlank protein was hypothesized. A former hypothesis claiming
the cleavage of the homeodomain from the full length protein could be disproved,
further supporting evidence of nuclear full length Schlank protein.
It has been shown, that distinct mutations within the schlank gene led to different
phenotypes. The deficiency of the enzyme does not only affect it’s metabolites but also
does the lack of the protein itself influence cell function. This fact may be important
when analyzing metabolite functions in vivo using knock out animals. It may be true
for other enzymes as well, especially if their domain structure is complex.
A hypothetical model of Schlank function is shown in figure 5.1: Part of the ex-
pressed Schlank protein localizes to the ER and is involved in the biosynthesis of
ceramides and sphingolipids in general. Sphingolipids (SL) are important for mem-
brane function and structure, but also known to have signaling properties. Reduction
of SL inhibits survival, development and growth.
Another pool of expressed Schlank protein localizes to the nucleus where it may be
able to bind DNA via its homeodomain. Gene regulation via the Schlank protein has
been observed e.g. for lipase 3 which is involved in lipolysis. Less storage fat may in
turn influence energy balance and growth.
Cleavage of the Schlank protein may be involved in the regulation of Schlank local-
ization, CerS activity or gene expression.
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Figure 5.1: Hypothetical model of Schlank function. Nuclear and ER Schlank pool may
have independent functions: Sphingolipid biosynthesis is dependent on the lag motif (green),
whereas regulation of lipase 3 gene expression and TAG level are dependent on the Schlank
homeodomain (blue). Both pools therefore influence survival and growth.
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6 Appendix
6.1 Rescue of schlank mutants
Over expression studies showed that lipase 3 transcript level are dependent on Schlank
protein expression, specifically the homeodomain containing Schlank N-terminus. To
further analyze this, classical rescue experiments were performed. The weaker schlank
mutant allele was "rescued" using the driver line cgGal4 that drives expression mainly
in the fatbody and haemocytes, and different UAS-lines. lipase 3 expression was used
as readout.
Figure 6.1 shows that expression of full length Schlank results in a reduced lipase 3
expression as compared to the schlank mutant. Also the expression of the catalyti-
cally inactive Schlank version (SchlankH215D) and the 138 N-terminal amino acids of
Schlank result in a reduced lipase 3 transcript level. Reduction is to about 30 % in
all cases.
Figure 6.1: Classical schlank rescue. The weaker schlankP (X)61 mutant and thecgGal4
driver line were used. The readout was qRT-PCR on lipase 3 transcript level. UAS-lines to
rescue the mutant phenotype (=up regulation of lipase 3 ) were UAS-HAschlank (full length
Schlank), UAS-schlankH215D (catalytically inactive Schlank) and UAS-eGFPschlankAA1-
138 (Schlank N-terminus until AA138). Error bars: SEM. Significance tested via Student’s
T-test. Level in schlankP (X)61 was set to 1.
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6.2 Subcellular localization of GFP-Schlank-AA1-138 in fatbody in vivo
6.2 Subcellular localization of GFP-Schlank-AA1-138
in fatbody in vivo
To check whether the schlank construct of AA 1-138 N-terminally eGFP-taged localizes
in vivo as it does in cell culture, immunofluorescent stainings of stage 3 larval fatbody
was performed.
As seen in figure 6.2 it localizes mostly to the nuclei which are outlined by the
αLamin staining. In oregonR fatbody no signal is detected which shows αGFP anti-
body specificity.
Figure 6.2: Subcellular localization of GFP-Schlank-AA1-138 in vivo. Males of the driver
line cgGal4 were crossed to virgins of the UAS GFPschlank AA1-138 line. Stage 3 larval
fatbody was stained with αGFP and αLamin antibodies. oregonR was used as a control.
Scale bars: 20 µm.
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6.3 Expression and subcellular localization of truncated
Schlank versions in vivo
Immunoblot analysis showed a Schlank cleavage site at around AA 98. Resulting
putative cleavage products (Schlank1-98 and Schlank99-400) were cloned into pUAST
in a tagged form to establish UAS fly lines. The lines were checked for the expression
of the constructs and their subcellular localization. Males of the indicated driver lines
(hsGal4, hsflp;act>CD2>Gal4, cgGal4 ) were crossed to virgins of the different UAS
lines. Stage 3 larval fatbody was stained with αHA and αLamin antibodies.
Like full length Schlank (upper three rows) the truncated Schlank versions localize
to a cytosolic region surrounding the nuclei (fig. 6.3). Expression of AA 1-98 was
rather low. Expression of Schlank in clones (hsflp;act>CD2>Gal4 = CD2G4 ) showed
the αHA antibody specificity as in cells where no schlank is expressed no staining was
detected.
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6.3 Expression and subcellular localization of truncated Schlank versions in vivo
Figure 6.3: Expression and subcellular localization of Schlank over expression constructs
in vivo. Scale bars: 20 µm.
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Appendix
6.4 Sub-cellular localization of Schlank in larval
fatbody
Ceramide Synthases have been described as transmembrane proteins localized to the
ER (Tidhar and Futerman, 2013; Stiban et al., 2008). Also, Schlank was shown to
localize to the ER, and to the nucleus in vivo (Voelzmann, 2013). However, much
of the detected Schlank protein could not be assigned to an organell. Here, co-
localization studies were performed with Spectrin (a cytoskeleton component underly-
ing the plasma membrane), mitoGFP (expressed GFP targeted to mitochondria) and
lampGFP (expressed GFP targeted to lysosomes). Schlank showed partial co-staining
with Spectrin and lampGFP, but no convincing co-staining with the mitochondrial
marker in the fatbody of stage 3 larvae (fig. 6.4).
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6.4 Sub-cellular localization of Schlank in larval fatbody
Figure 6.4: Schlank subcellular localization in L3 fatbody cells. Antibody (αSchlank-
CT) specificity was tested using schlankRNAi clones. mitoGFP and lampGFP were over
expressed using the hsGal4 or lsp2Gal4 driver line, respectively. Fatbody was dissected and
stained in third larval stage.
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6.5

Abbreviations
A. bidest double destilled water
AA amino acid
AEL after egg laying
Amp ampicillin (resistance cDNA)
ATP adenosine triphosphate
APS ammonium peroxide sulfate
bp base pairs
BSA bovine serum albumin
cDNA complementary DNA
Cer Ceramide
CerS Ceranide Synthase
C-Terminus carboxy terminus of a peptide
CyO Curly of Oyster (marker)
Da Dalton
DAPI 4’,6-diamidino-2-phenylindole
DMSO dimethyl sulfoxide
DNA desoxy ribonucleic acid
dNTP 2’-desoxy-nucleoside- 5’-triphosphate
E. coli Escherichia coli
ECL enhanced chemo luminescence
EDTA ethylenediaminetetraacetic acid
e.g. for example (lat.: exempli gratia)
eGFP enhanced green fluorescent protein
ER endoplasmic reticulum
et al. and others (lat.: et altera)
Fig. figure
FM7 balancer chromosome (X)
frt Flp-recombinase recognition target
gDNA genomic DNA
h hour
HR homologous region
HRP Horseradish Peroxidase
hs heat shock
INM inner nuclear membrane
kb kilo base pairs
kDa kilo dalton
KI knock-in
KO knock-out
l liter
L larval stage (1,2,3)
loxP locus of crossing over P1
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6.5
m milli
MCS Multiple Cloning Site
min Minute
mRNA messenger-RNA
n nano
n independent biological replicates
NLS nuclear localization sequence
N-terminus amino terminus of a peptide
ORF open reading frame
p pico
PAGE polyacrylamide gel electrophoresis
PBS phosphate buffered saline
PCR polymerase chain reaction
PFA paraform aldehyde
polyA polyadenylation site
RNA ribonucleic acid
RNAi RNA interference
RT room temperature
S1P sphingosine-1-phosphate
SEM standard error of the means
SDS sodium dodecyl sulfate
TAG triacylglycerol
TBS tris buffered saline
TEMED N,N,N’,N’-Tetramethyl-ethylendiamin
TLC thin layer chromatography
TM trans membrane (domain)
TM3 balancer chromosome (3rd)
Tris tris-(hydroxymethyl)- aminomethane
U unit
UAS Upstream Activating Sequence
UTR untranslated region
v volume
V Volt
WT wildtype
YFP yellow fluorescent protein
+ WT chromosome
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